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 CHAPTER 1 
INTRODUCTION1 
 
The prevalence of blast injuries  
 Blast trauma has become increasingly commonplace over the past several 
decades. According to the RAND Database of Worldwide Terrorism Incidents 
(http://www.rand.org/nsrd/projects/terrorism-incidents.html), the number of terrorist 
bombings increased from 1,190 in the 1970’s to 15,239 in the 2000’s. Collectively, these 
explosive attacks injured 118,018 people and killed 36,518 people worldwide.  In the 
United States alone, 28,529 bombings injured 5,931 people and killed 699 people within 
a 20 year period (Kapur et al., 2005). 
 Blast trauma is also the hallmark injury of recent conflicts in Iraq and 
Afghanistan, accounting for 80% of all injuries reported to the Joint Theater Trauma 
Registry (Bass et al., 2012). Ocular blast injuries are common among blast-exposed 
veterans, with over 186,000 veterans diagnosed with ocular injuries over a ten year 
period (Hilber, 2011). Ocular blast injury is also a common comorbid condition with 
traumatic brain injury and was estimated to affect 66% of veterans with mild traumatic 
brain injury (Weichel et al., 2009). Ocular blast trauma encompasses a wide variety of 
clinical and pathological manifestations, which is likely due to the multiple injurious 
components of explosive devices (DePalma et al., 2005; Scott, 2011). 
 
 
                                            
1 Portions of this chapter were published as Bricker-Anthony, C (2014). Ocular blast 
trauma: models, mechanisms, and a potential therapeutic strategy. VRN 6. 
 2 
Categorizing blast injuries 
 Blast injuries are split into four major categories: primary, secondary, tertiary and 
quaternary (Scott, 2011). Explosive devices emit a shockwave or overpressure airwave 
upon detonation that causes primary blast injuries. Computer modeling of primary 
ocular blast injuries predicts sharp increases in intraocular pressure, tissue strain and 
reflection and amplification of pressure waves within the orbit upon exposure to a blast 
wave (Rossi et al., 2012).  Clinically, primary ocular blast injuries are indistinguishable 
from those caused by blunt force trauma, as both injury mechanisms can cause 
cataracts, vitreous hemorrhage, retinal edema and traumatic optic neuropathy (Scott, 
2011).  
 Shrapnel and other flying debris from an explosion cause secondary ocular blast 
injuries (Scott, 2011). Secondary ocular blast injuries include perforations, contusions, 
lacerations and corneal or intraocular foreign bodies. Pathological features of secondary 
ocular blast injury include corneal abrasions, damage to structures of the anterior 
chamber (iris, ciliary body, trabecular meshwork, lens), hyphema, commotio retinae, 
globe rupture and traumatic optic neuropathy (Scott, 2011). 
 The remaining two categories of blast injury, tertiary and quaternary, are caused 
by being thrown against objects and chemical/thermal burns, respectively (Scott, 2011). 
Tertiary ocular blast trauma can manifest as Purtscher’s retinopathy, a condition 
characterized by vaso-occulsion and hemorrhages in the retinal vasculature (Scott, 
2011). Chemical and thermal burns typically damage the sclera, corneal epithelium and 
conjunctiva. 
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Categorizing ocular blast trauma 
Given the complex nature of explosions, it is no surprise that ocular blast injuries 
vary widely in severity and visual prognosis from one individual to the next (Erdurman et 
al., 2011; Phillips et al., 2013; Weichel et al., 2009). These diverse injuries are further 
classified as either closed globe injuries (contusions and lamellar lacerations) or open 
globe injuries (Scott, 2011). Both closed and open globe injuries negatively impact 
vision, but open globe injuries are typically associated with poorer visual outcomes 
(Erdurman et al., 2011). 
 Despite occupying different categories, closed and open globe injuries share 
much common pathology. Both can cause corneal abrasions, hyphema, cataracts, 
retinal detachment, optic neuropathy and retinal pigment epitheliopathy (Alam et al., 
2012; Cockerham et al., 2011; Erdurman et al., 2011; Phillips et al., 2013; Thach et al., 
2008). The main difference between the two injury types is the physical disruption of 
ocular immune privilege with open globe injuries.  
 The eye is a tightly regulated, immune privileged space that works in concert with 
the spleen to preserve the integrity of the visual axis (Streilein, 2003). Ocular immune 
privilege consists of both physical barriers and a complex signaling cascade known as 
anterior chamber-associated immune deviation (ACAID). Immune privilege within the 
eye exists to provide controlled responses to infection and injury, avoiding excessive 
production of inflammatory cytokines that can lead to corneal and lens opacification, as 
well as retinal edema (Streilein, 2003). Loss of immune privilege and the ensuing 
inflammation likely contributes to vision loss after blast-induced open globe injuries. 
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Modeling ocular blast trauma: differences in murine and human ocular anatomy 
Every model of human injury or disease confronts several common limitations. 
Species differences are a substantial challenge for every researcher wishing to mimic 
any disease or injury in a controlled environment. As with most pre-clinical research, in 
vivo ocular blast injury models are currently limited to rodents (Hines-Beard et al., 2012; 
Mohan et al., 2013; Por et al., 2016; Wang et al., 2014; Zou et al., 2013). Numerous 
transgenic and knockout mice are commercially available to study human genetic 
diseases, which gives mice a slight advantage over rats. In terms of basic anatomy, the 
eyes of mice and rats are quite similar to human eyes, with some exceptions. Since 
mice are the most commonly used animals in ocular blast models, I will focus on this 
species. 
 Humans have a well-defined lamina cribrosa, a meshwork of elastin and collagen 
fibers through which the retinal ganglion cell axons converge and exit the eye 
(Hernandez, 1992). In contrast, mice lack an identifiable lamina cribrosa and instead 
have a glial lamina composed of astrocytes (Tansley, 1956). Pathological changes in 
the lamina cribrosa are associated with several forms of glaucoma, especially primary 
open-angle glaucoma (Hernandez, 1992). At the present time, it is not clear how much 
stress ocular blast trauma exerts upon the optic nerve head and lamina cribrosa in the 
patient population. Potentially, mechanical stress from blast exerted upon the human 
lamina cribrosa could cause the elastin and collagen fibers to physically impinge upon 
the retinal ganglion cell axons, causing direct injury. Injury to the human lamina cribrosa 
could also cause increased secretion of matrix metalloproteinases from reactive 
astrocytes over time, leading to damaging, long-term structural changes (Agapova et 
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al., 2001). In the mouse glial lamina, mechanical stress could lead to reactive gliosis of 
the astrocytes, ultimately also leading to pinching of the retinal ganglion cell axons. 
Blast could also stretch the axons and cause direct injury. 
 Another key species difference between rodents and humans is the lens. The 
lens is a translucent structure in the anterior chamber of the eye, composed primarily of 
α-A and B crystallins (Bloemendal et al., 2004). The structure and conformation of the 
crystallins contributes to the refractive index of the eye (Bloemendal et al., 2004). While 
the proteins within the lens are largely the same between species, the shape and size of 
the lens vary, which results in differences in how light travels through the lens. Mouse 
and rat lenses are spherical in shape and take up a substantial amount of space within 
eye, when compared to the human lens (Lei and Yao, 2006). This difference in lens size 
between mice, rats and humans may pose an issue for models of ocular blast trauma. A 
larger lens may result in higher numbers of traumatic cataracts, which only occurred in 
6% of Veterans in a recent study (Cockerham et al., 2011). Using a porcine model 
instead of a rodent model may be better for lens research in ocular blast trauma, as the 
porcine lens is similar in shape and size to the human lens (Lei and Yao, 2006). 
 Additional differences include the structure and photoreceptor populations of the 
retina. The ratio of rods to cones varies between the human and mouse retina, with 
95% rods to 5% cones in the human retina (Curcio et al., 1990) and 97% rods and 3% 
cones in the mouse retina (Carter-Dawson and Lavail, 1979). Humans are also 
trichromats, with short, medium and long wavelength cones, while mice are dichromats 
and only have short and medium wavelength cones (Huberman and Niell, 2011). The 
human retina contains a foveal pit densely and exclusively packed with cone 
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photoreceptors. The fovea is important for high acuity vision, which is created by low 
convergence of cones to retinal ganglion cells (1:1) and downstream magnification of 
the foveal representation within the visual cortex (Curcio and Allen, 1990). In contrast, 
there is no analogous structure to the fovea in the mouse retina. Instead, cones in the 
mouse retina are segregated by wavelength in the dorsal and ventral retina (Szel et al., 
1993). Cockerham and colleagues reported macular damage in 15% of veterans with 
ocular blast trauma (Cockerham et al., 2011). A recent finite element model of human 
ocular blast trauma also predicted significant strain on the macula (Rossi et al., 2012). In 
order to appropriately model visual deficits created by damage to the macula, an 
alternative to the mouse is required. One of the few other species with a macula and 
fovea is the non-human primate. Other smaller mammalian alternatives include the cat 
and the ferret, which lack a fovea and macula but have an area centralis, a region in the 
central retina specialized for high acuity vision (Rapaport and Stone, 1984). 
 Even though mice lack some important ocular anatomical structures seen in 
humans, the structure and function of the anterior chamber of the eye (cornea, iris, 
aqueous humor, angle, ciliary body) are largely the same in both species. Furthermore, 
the cell biology of the retina is highly conserved between the two species. Much of our 
understanding of phototransduction comes from studies conducted in mouse models 
(Calvert et al., 2000; Humphries et al., 1997). While mice rely heavily upon olfaction to 
learn about their environment, they also have well-characterized responses to tests of 
visual function, including visual acuity, contrast sensitivity and evoked potentials 
(Douglas et al., 2005; Hetling and Pepperberg, 1999). Thus, despite some limitations, a 
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mouse model is appropriate for studying basic biological responses and changes in 
retinal cell physiology following ocular blast trauma. 
 
Current models of ocular blast trauma 
 To date, most ocular blast trauma models only manage to reproduce certain 
aspects of the plethora of possible pathologies. Additionally, there are no models of 
open globe blast injury. Current models of ocular blast injury include the shock tube 
(Mohan et al., 2013; Por et al., 2016; Wang et al., 2014), trinitrotoluene (Zou et al., 
2013) and modified paintball marker (Hines-Beard et al., 2012).   
 
Shock tube model 
The shock tube model is a two-chambered apparatus divided by a mylar 
membrane. Compressed air is pumped into one chamber until the mylar membrane 
ruptures and releases an overpressure airwave into the neighboring chamber, which 
contains a rat or mouse. Animal placement and restraints vary among researchers and 
range from full head exposure with body shielding to full body exposure. The shock tube 
produces low-level overpressure waves ranging from 9.9-20 psi; 20psi is the minimum 
pressure level for damaging air-filled organs such as the ears and lungs in humans 
(DePalma et al., 2005). However, repeated exposure to blast pressures as low as 6psi 
is associated with abnormal changes in visual field and cell loss within the cornea in 
soldiers during breacher training (Capó-Aponte et al., 2015), so the eye is potentially 
more vulnerable to low-level blasts. These low-level blasts produce a mild injury 
phenotype with corneal inflammation and neutrophil infiltration (Por et al., 2016), cell 
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death within the inner retina and optic nerve pathology (Mohan et al., 2013; Wang et al., 
2014), reduced nerve fiber layer thickness (Mohan et al., 2013), acute increases in 
oxidative stress and degenerative markers and a reduction in pattern electroretinogram 
(pERG) amplitude (Mohan et al., 2013).  
Corneal damage (Por et al., 2016) is consistent with previous findings in blast-
exposed individuals (Capó-Aponte et al., 2015; Cockerham et al., 2013; Yonekawa et 
al., 2014). Transient potential vanilloid 1 channel, endothelin 1, calcitonin gene-related 
peptide and substance P increases in the cornea (Por et al., 2016) are unsurprising, 
given the well-established roles of these proteins in nociception (Julius and Basbaum, 
2001; Plant et al., 2007). Ocular discomfort is common complaint in blast-exposed 
patients (Cockerham et al., 2013), so targeted antagonists for nociceptors in the cornea 
may prove effective at reducing ocular surface pain. 
Neutrophil infiltration in the cornea in Por and colleagues’ model is important as 
peripheral immune cell infiltration indicates loss of ACAID in the absence of an open 
wound. While neutrophils are effective at combating bacterial infections and 
phagocytosing debris in peripheral sites, they pose a significant threat to the cornea and 
the rest of the anterior chamber due to their excretion of reactive oxygen species, 
reactive nitrogen species and inflammatory cytokines (Smith, 1994). Neutrophil-
mediated inflammation in the cornea can eventually lead to corneal opacities and 
blindness (Hall et al., 2001).  
Retinal ganglion cell death (Wang et al., 2014), retinal nerve fiber layer thinning 
(Mohan et al., 2013) and optic nerve degeneration (Mohan et al., 2013; Wang et al., 
2014) also align with previously identified pathology in blast-exposed veterans 
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(Cockerham et al., 2009, 2011; Weichel et al., 2008). The decreased pERG amplitudes 
and lack of full-field ERG deficits in this model represent the functional outcomes of 
retinal ganglion cell dysfunction and loss, as the pERG response is specific to retinal 
ganglion cells (Maffei et al., 1985).  Blast-induced optic nerve injury is also associated 
with poor visual outcomes (Cockerham et al., 2009; Weichel et al., 2008) and is thought 
to progress in stages (Samardzic et al., 2012).   
It is currently postulated that the first stage of traumatic optic neuropathy is 
mechanical insult to the nerve, such as axonal shearing from globe rotation or a 
penetrating injury, while the second stage is ischemia in the supporting vasculature 
(Steinsapir and Goldberg, 1994). These injury phases cause retinal ganglion cell death, 
inflammation and permanent vision loss in roughly half of patients (Steinsapir and 
Goldberg, 1994). Unfortunately, the only available treatments are large doses of 
corticosteroids and decompression surgery (Samardzic et al., 2012; Steinsapir and 
Goldberg, 1994). These treatment measures are less effective than observation alone 
(Levin et al., 1999), which suggests that the true molecular mechanisms of traumatic 
optic neuropathy are still unknown. 
Both oxidative stress and beta amyloid are known participants in 
neurodegenerative changes in several brain and eye diseases and trauma (Dentchev et 
al., 2003; Ethen et al., 2007; Hardy and Selkoe, 2002; Petersen and Doorn, 2004; 
Readnower et al., 2010). The presence of 4-hydroxynonenal (4-HNE) in the retina is 
particularly troubling due to its known cytotoxic effects (Niki et al., 2005). Beta amyloid 
is also highly toxic to retinal neurons (Jen et al., 1998) and works synergistically with 4-
HNE to disrupt cell membrane integrity and neuronal ion homeostasis (Mark et al., 
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1997). 4-HNE and beta amyloid were only observed acutely in the shock tube model 
and likely represent the first phases of blast-induced neurodegeneration (Mohan et al., 
2013).  
However, the shock tube model does not appear to damage other anterior 
structures such as the lens, iris and pupil (Mohan et al., 2013; Wang et al., 2014). There 
are also no reports of gross pathology (edema, hyphema or neovascularization), outer 
retinal damage (retinal detachments or outer nuclear layer thinning) or pathological 
changes in the RPE (retinal pigment epitheliopathy or vacuoles). Another potential issue 
with this model is that the blast is head-directed and not eye-directed. While it may be 
more valid to opt for full head exposure, it becomes difficult to determine whether the 
changes in the inner retina and optic nerve are due to ocular injury or brain injury from 
blast. 
A previous study identified axon degeneration in primary visual pathway and 
inner retinal cell death after a head-directed blast (Koliatsos et al., 2011). Axonal 
shearing in the optic nerve during blast exposure could initiate Wallerian degeneration 
of the retinal ganglion cells in the inner retina (Strich, 1961). Currently, the shock tube 
model is an ideal platform for further characterization of visual deficits in mild traumatic 
brain injury, but is unlikely to provide specific information about the pathogenesis of 
ocular blast trauma. 
 
TNT model 
While the TNT model of ocular blast trauma also utilizes a whole head exposure 
approach, it succeeds in inducing some pathology absent in the shock tube model and 
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accurately recapitulates both primary (overpressure wave) and quaternary (thermal 
exposure) aspects of blast injury (Zou et al., 2013). This model also incorporates two 
blast pressures into a single study, including both 70psi and 26psi blasts, which are 
much higher than the pressures in the shock tube model. A 26psi blast is sufficient to 
injure the ears, lungs and eyes and possibly the brain and spinal cord, while a 70psi 
blast can injure nearly every organ in the human body (DePalma et al., 2005). The body 
is shielded and restrained in this model, which prevents secondary and tertiary injuries, 
as well as internal organ damage. Unfortunately, the authors did not provide any 
information regarding the anterior chamber or assess visual function after blast.  
In contrast with the shock tube model, the TNT model mainly elicits cell death in 
the outer retina, as well as increased retinal thickness. The authors also show that 
increased inducible nitric oxide, aquaporin-4 and vascular endothelial growth factor 
immunostaining mostly occur within the inner retina, which suggests a significant 
inflammatory immune response and the potential for future cell death within the inner 
retina. Additionally, the increased retinal thickness and aquaporin-4 expression imply 
retinal edema, which is one of the clinical manifestations of ocular blast injury (Abbotts 
et al., 2007). Surprisingly, the 26psi and 70psi blasts induce similar retinal pathology; 
this finding suggests that both moderate and high-pressure level blasts are equally 
damaging when the body is shielded. Overall, the TNT model successfully recapitulates 
some features of ocular blast injury, but needs further characterization with gross 
pathology and visual function assessments to determine whether it truly reproduces the 
injuries observed in clinical settings. 
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Modified paintball marker 
Our laboratory utilizes the modified paintball marker model (Hines-Beard et al., 
2012). This model system consists of a paintball marker with a machined barrel that 
produces overpressure airwaves. C57Bl/6J (Bl/6) mice are secured and completely 
shielded from the overpressure wave, with the exception of the exposed left eye. This 
model system is unique because it isolates primary blast trauma to eye alone; this 
allows us to study the effects of blast exposure on the neural retina and optic nerve 
without contributions from traumatic brain injury.  
Unlike the shock tube model, the modified paintball marker damages multiple 
anterior structures, including the cornea, lens and extraocular muscles. Intraocular 
pressure (IOP) decreases significantly over time after blast exposure, which is indicative 
anterior chamber inflammation and/or injury to the iris or ciliary body (Sanders, SP, 
2016). Damage to the anterior chamber is also a significant risk factor for the 
development of post-traumatic glaucoma (Ozer et al., 2007). 
The modified paintball marker also injures the retina. Outer retinal thinning 
occurs in a small area in the mid-peripheral after injury. Discrete areas of outer retinal 
thinning (due photoreceptor loss) are commonly observed in commotio retinae and 
ballistic trauma (Blanch et al., 2012; Blight and Hart, 1977; Sipperley et al., 1978), which 
suggests the model has a blunt injury component. Blast-exposed individuals also 
experience retinal thinning in the macula, an area highly enriched with photoreceptors 
(Phillips et al., 2013).  
Additionally, the model induces decreased visual acuity, as measured by 
optokinectic nystagmus (OKN), in a subset of animals.  In a previous study, over 30% of 
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blast-exposed veterans with ocular injuries had no light perception, while 75% of the 
veterans with open globe injuries had a final best-corrected visual acuity of 20/200 or 
less (Weichel and Colyer, 2008). Since we only measured visual acuity in mice without 
corneal or lens opacities, the changes were likely due to retinal injury. In the mouse, 
functional directional-selective retinal ganglion cells and starburst amacrine cells are 
necessary for the OKN response (Yoshida et al., 2001). Therefore, our model system 
potentially induces both inner and outer retinal injuries. 
Given the ability of our model system to recapitulate multiple features of ocular 
blast injury, we decided to continue characterizing any cellular and molecular changes 
that occurred after injury. Since ocular blast injuries vary widely in affected individuals, 
we characterized the injury response in two additional inbred strains of mice, the 
DBA/2J (D2) and Balb/cJ strains, to determine if different genetic backgrounds would 
respond uniformly to injury. Following our initial characterization of Bl/6 mice, we chose 
26psi as our pressure level of choice moving forward because it consistently induced 
ocular injuries with a fairly low mortality rate (Hines-Beard et al., 2012). 
 
Summary and specific aims of dissertation 
 Ocular blast trauma is a persistent threat to vision in both civilian and military 
populations. There are currently no treatments that can block degeneration of the retina 
or optic nerve following ocular blast injury. The specific molecular mechanisms 
underlying ocular blast trauma are also currently unknown. Given our laboratory’s ability 
to effectively recapitulate key features of ocular blast trauma in the mouse (Hines-Beard 
et al., 2012), we will further characterize the pathological effects of our model system on 
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the murine retina and optic nerve. Oxidative stress is a common marker of blast trauma, 
so we will assess the role of oxidative stress in the pathogenesis of ocular blast trauma. 
Since EPO has both neuroprotective and antioxidant properties, we will evaluate its 
efficacy for the treatment of ocular blast trauma. We hypothesize that ocular blast 
trauma causes both acute and long-term neurodegeneration and vision loss that can be 
blocked by decreasing oxidative stress after blast with EPO treatment. The specific 
goals of this study are to characterize the progression of neuronal degeneration, test the 
efficacy of EPO and EPO-R76E at reducing oxidative stress and preserving vision after 
blast and elucidate the role of oxidative stress.  
 
 Aim 1. Determine the progression of neuronal degeneration and vision loss after 
blast. We will test the hypothesis that ocular blast trauma induces both acute and long-
term neuronal injury and vision loss.  
We will expose adult Balb/cJ, C57Bl/6J and DBA2/J mice to an eye-directed 
blast. Assessments of visual function will include optokinetics (OKN) and 
electroretinogram (ERG). We will collect eyes at 3 days and 1 week (acute) or at 1 
month (long-term) post-injury to measure retinal structure. Markers of cell death, lipid 
peroxidation and nitrosylation will be examined using immunohistochemistry (IHC). Both 
ipsilateral and contralateral eyes will be examined. 
 
Aim 2. Test the efficacy of EPO-R76E as an antioxidant and neuroprotective agent 
for blast injury. We will test the hypothesis that acute treatment via EPO protein and 
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long-term treatment via gene therapy with rAAV2/8.Epo-R76E will protect the retina 
from blast injury by reducing oxidative stress. 
 Prior to blast, C57Bl/6J mice will receive an intramuscular injection of viral vector 
delivering Epo-R76E. Assessments of visual function will include OKN and ERG. We 
will collect eyes at 28 days and 3 months post-injury to measure retinal structure and 
cell death. We will perform: 1) in vivo imaging to quantify levels of hydrogen peroxide 
and superoxide, 2) an oxidative stress RT-PCR array, and 3) immunolabeling with 
markers of lipid peroxidation, nitrosylation, and cell death. Both ipsilateral and 
contralateral eyes will be examined. 
 
Specific Aim 3: Determine the role of oxidative stress in neuronal degeneration 
and vision loss after blast. We will test the hypothesis that vision loss after blast is 
mediated by oxidative-stress.  
Aim 3A: To test if decreased antioxidant load will exacerbate blast-induced injury, 
C57Bl/6J mice will be compared to low vitamin C Gulo-/- mice after an eye-directed 
blast. 
Aim 3B: To test if increased antioxidant load will protect the retina from blast injury by 
decreasing oxidative stress, C57Bl/6J mice will be maintained on a high antioxidant 
regimen, consisting of dietary supplementation of both vitamin C and E, prior to and 
following blast. 
 Assessments of visual function will include OKN and ERG. We will collect eyes 
at both acute (3 days and 1 week) and long-term (1 month) time points post-injury to 
measure retinal structure and cell death. We will perform: 1) in vivo imaging to quantify 
 16 
levels of hydrogen peroxide and superoxide, 2) an oxidative stress RT-PCR array, and 
3) immunolabeling with markers of lipid peroxidation, nitrosylation, and cell death. Both 
ipsilateral and contralateral eyes will be examined. 
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CHAPTER 2 
 
OCULAR BLAST TRAUMA ELICITS RETINAL CELL DEATH, NITROSATIVE 
STRESS AND VISUAL DEFICITS IN THREE GENETICALLY DISTINCT INBRED 
MOUSE LINES2 
Introduction 
 Genetic susceptibility contributes the pathogenesis of multiple human diseases 
and injuries, including glaucoma (Libby et al., 2005), age-related macular degeneration 
(Abecasis et al., 2004), traumatic brain injury (Friedman et al., 1999) and sympathetic 
ophthalmia (Kilmartin et al., 2001). Several studies have also uncovered varying 
degrees of genetic susceptibility to ischemia/reperfusion injury (Burne et al., 2000), 
experimental autoimmune uveitis (Sun et al., 1997) and optic nerve crush (Li et al., 
2007) among different strains of inbred mice. Different alleles or even single nucleotide 
polymorphisms can dramatically alter biological responses to injury or disease. For 
example, in both Alzheimer’s disease and traumatic brain injury, the apolipoprotein E4 
allele of the APOE gene reduces amyloid-beta clearance and interferes with 
phospholipid metabolism, which results in the accumulation of toxic amyloid-beta 
                                            
2 Portions of this chapter were published as Bricker-Anthony C, Hines-Beard J and Rex 
T (2014) Molecular changes and vision loss in a mouse model of closed-globe blast 
trauma. IOVS 55:4853-4862; Bricker-Anthony C, Hines-Beard J, D’Surney L and Rex 
TS (2014) Exacerbation of blast-induced ocular trauma by an immune response. J 
Neuroinflammation 11: 192; Bricker-Anthony C and Rex TS (2015) Neurodegeneration 
and vision loss after mild blunt trauma in the C57Bl/6J and DBA/2J mouse. PLOS One 
10(7); Bricker-Anthony C, Hines-Beard J and Rex TS (2016) Eye-directed overpressure 
airwave-induced trauma causes lasting damage to the anterior and posterior globe: a 
model for testing cell-based therapies. J Ocul Pharmacol Ther Epub ahead of print. 
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plaques, impaired synaptic function and exacerbation of disease or injury (Zhu et al., 
2015). 
Currently, the role of genetic susceptibility in ocular blast injury is unknown. 
Responses to ocular blast injury in human patients vary widely in terms of pathological 
features and visual outcomes (Weichel et al., 2008; Erdurman et al., 2011), but this 
could due to differences in injury mechanism (e.g., primary vs. secondary blast injury) or 
severity (closed vs. open globe injury). However, genetic susceptibility should not be 
ruled out as a contributing factor to the pathogenesis of ocular blast injury, as a simple 
genetic variant could protect against injury or exacerbate it. Given the genetic 
heterogeneity of the human population, a single inbred mouse strain is unlikely to 
capture the full range of potential genetic susceptibility to ocular blast injury. Therefore, 
we decided to characterize our model of ocular blast injury in three inbred strains of 
mice commonly used in vision research, including C57Bl/6J (Bl/6) mice, Balb/cJ mice 
and DBA/2J (D2) mice, which are summarized below.  
The Bl/6 is one of the most widely used inbred mouse strains in laboratory 
research, often serves as the background strain for transgenic and knockout mice and 
is well-characterized on a wide variety of behavioral assessments (Crawley et al., 
1997). The Bl/6 strain is also one of the parental strains (the other parental strain is the 
D2, described below) for the BXD recombinant inbred mouse line, which is used to map 
complex genetic traits and explore gene function (Peirce et al., 2004). Among inbred 
mouse strains, Bl/6 mice are mildly susceptible to both optic nerve injury (Li et al., 2007) 
and experimental glaucoma (Cone et al., 2010) and are highly resistant to light-induced 
retinal degeneration (Wenzel et al., 2001). While the genes underlying the Bl/6 mouse’s 
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susceptibility to various ocular insults are still being actively pursued, there is some 
evidence suggesting that downregulation of crystallin gene expression after optic nerve 
injury may exacerbate axon loss in the Bl/6 mouse (Templeton et al., 2009). 
Additionally, a variation in the RPE65 gene in the Bl/6 mouse reduces recycling of 
rhodopsin in the RPE and reduces light-induced apoptosis of rod photoreceptors 
(Wenzel et al., 2001). Altogether, the Bl/6 mouse is ideal for characterization of ocular 
blast injury because it allows for comparison to other models of blast injury using Bl/6 
mice, is only mildly susceptible to ocular injury and could be used to explore potential 
genetic contributors to ocular blast injury. 
D2 mice are commonly used in vision research as an animal model of 
pigmentary dispersion glaucoma (Libby et al., 2005). Mutations in two genes that 
encode melanosomal proteins, GPNMP and TYRP1, cause leakage of toxic 
intermediates from melanin production in melanosomes, which leads to inflammation, 
pigment dispersion and IOP elevation in the D2 mouse (Anderson et al., 2002). The D2 
mouse develops glaucoma at approximately 6 months of age (John et al., 1998), but 
reactive microglia are present in the D2 retina at 3 months of age, indicating a 
heightened neuroinflammatory state prior to the onset of glaucoma (Bosco et al., 2011). 
In addition to the glaucoma-related mutations, there are also deletions in the C5 gene 
and CD94 gene that result in complement component 5 deficiency (Wetsel et al., 1990) 
and lack of cell surface expression of CD94 (Wilhelm et al., 2003), respectively. C5 is 
involved in all three complement cascades (classical, alternative and lectin pathways) 
and is critical for assembly of the membrane attack complex, which forms in the 
membrane of target cells and initiates lysis (Howell et al., 2013). C5 deficiency makes 
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the D2 mouse more vulnerable to infection; however, restoration of C5 expression in the 
D2 exacerbates glaucoma possibly through deposition of the membrane attack complex 
in diseased retinal ganglion cells (Howell et al., 2013). CD94 is important for induction of 
anterior chamber-associated immune deviation (ACAID), a molecular cascade that 
maintains ocular immune privilege in the anterior chamber after infection or injury (He et 
al., 2008). The lack of CD94 expression in the D2 mouse results in defective ACAID 
signaling, which allows peripheral immune infiltrate to enter the anterior chamber in 
response to infection or injury (Chattopadhyay et al., 2008). Surprisingly, despite their 
susceptibility to glaucoma, D2 mice are highly resistant to optic nerve injury (Li et al., 
2007; Templeton et al., 2009). After optic nerve injury, crystallin gene expression 
increases in the D2 and may exert a protective effect (Templeton et al., 2009). Overall, 
the D2 mouse is another good candidate for characterization of ocular blast injury 
because it allows for exploration of altered immune status in an injured state and, like 
the Bl/6, can also be used to research potential genetic contributors to ocular injury. 
Balb/cJ mice are another widely used inbred strain in laboratory research that 
have been historically used for antibody production and autoimmune research (Pal-
Ghosh et al., 2008). When compared to other inbred strains like the Bl/6 and D2, the 
Balb/cJ strain is highly susceptible to optic nerve injury (Li et al., 2007). The genetic 
differences underlying the Balb/cJ’s susceptibility to optic nerve injury are currently 
unknown, but several researchers have hypothesized that it is immune-mediated, as the 
Balb/cJ and Bl/6 vary in their immune responses to experimental autoimmune disease 
(Li et al., 2007; Kipnis et al., 2001). Other researchers have postulated that 
downregulation of genes involved in axonal regeneration and synaptic plasticity in the 
 21 
Balb/cJ after optic nerve injury exacerbate axonal degeneration, but it is unclear if these 
changes are unique to the Balb/cJ strain (Sharma et al., 2014). The Balb/cJ is also 
highly susceptible to retinal degeneration induced by light exposure, which is due to 
genetic variability in the RPE65 gene (Wenzel et al., 2001). Unlike the Bl/6, the Balb/cJ 
lacks the RPE65 Leu450Met variant and efficiently recycles rhodopsin during light 
exposure, allowing rhodopsin-mediated apoptosis of photoreceptors to occur (Wenzel et 
al., 2001). In conclusion, the Balb/cJ mouse is another good candidate for 
characterizing ocular blast injury as its susceptibility to optic nerve damage may make it 
useful for studying traumatic neuropathy after blast exposure. 
 To characterize the progression of ocular blast injury in all three mouse strains, 
we chose both acute (3 and 7 days) and long-term (1-2 months) time points. At multiple 
time points, we assessed gross pathology, in vivo retinal structure (OCT), visual 
responses (i.e. optokinetics and electroretinogram), retinal and optic nerve histology, 
mRNA expression (rt-PCR) and immunohistochemistry to provide a complete 
characterization of ocular blast injury in each mouse strain.  
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Materials and Methods 
Animals 
Three strains of commercially available mice, Bl/6 (n=89), D2 (n=170) and 
Balb/cJ (n=160) (The Jackson Laboratory, Bar Harbor, ME), between 8-12 weeks of age 
were used for our characterization studies. All mice were maintained on a 12hr 
light/dark cycle and provided food and water ad libitum. All experimental procedures 
were approved by the Institutional Animal Care and Use Committee of Vanderbilt 
University and were in accordance with the Association for Research in Vision and 
Ophthalmology Statement for the Use of Animals in Vision and Ophthalmic research. 
 
Ocular blast injury 
 For our initial experiments, mice were anesthetized with an intraperitoneal 
injection of ketamine/xylazine (105/8 mg/kg). Due to rising mouse mortality rates (22% 
and higher (Hines-Beard et al., 2012)), we switched to inhalable isofluorane (4%, Vet 
Equip, Pleasanton, CA), which caused a decline in the mortality rate. The mice were 
secured and padded within a housing chamber. The housing chamber was placed 
inside of a pipe. The left eye of the mouse was positioned against the hole in the pipe, 
which was aligned with the barrel of a paintball marker. All experiments were performed 
at a blast pressure of 26psi. Sham mice were anesthetized and placed in the housing 
chamber within the pipe like the blast mice, but a shield was placed between the marker 
barrel and the eye hold to prevent blast exposure. Mice were provided gel recovery food 
(Clear H2O, Portland, ME) for the first 3 days post-injury. Following initial 
characterization of the blast injury, we applied lubricating, non-medicated eye drops 
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(Systane Ultra drops, Alcon, Fort Worth, TX) to the corneas of both eyes immediately 
post-injury to prevent anterior pathologies, which allowed us to conduct assessments of 
visual function. 
 
Gross pathology 
The eyes of awake mice were assessed prior to blast injury and at 0, 3, 7, 14, 28 
and 60 days post-injury using an SZX16 stereomicroscope (Olympus, Center Valley, 
PA). Representative images were taken using a DP71 camera (Olympus). Eyes were 
examined for the presence of corneal abrasions, corneal edema, hyphemas, cataracts 
and corneal neovascularization (CNV).  
 
Ultra high resolution optical coherence tomography  
Mice were anesthetized with an intraperitoneal injection of ketamine/xylazine 
(25/10 mg/kg) or inhalable isofluorane (Vet Equip). A 1% tropicamide solution was used 
to dilate the eyes. Genteal lubricating eye gel (Alcon, Fort Worth, TX) was used to keep 
the eyes moist. The mice were wrapped in gauze, placed in a holding chamber and 
head position was stabilized with a bite bar. A Bioptigen ultra-high resolution spectral 
domain OCT system with a mouse retinal bore and cornea bore (Bioptigen LLC, 
Morrisville, NC) was used to image the retina and anterior chamber, respectively.  
 
Visual acuity  
Photopic spatial frequency thresholds (i.e. visual acuity) were assessed by 
optokinetic nystagmus (OKN) (OptoMotry, Canada) in awake mice at baseline and post-
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blast or sham. A step-wise, masked paradigm was used. Mice were acclimated to the 
testing chamber for 5 min prior to the initiation of each test. The speed of sinusoidal 
grating rotation and contrast were maintained at 0.042 c/d and 100%, respectively. 
 
Electroretinogram (ERG)  
Flash ERGs were performed at baseline and 28 days post-blast in mice dark-
adapted overnight, anesthetized with ketamine/xylazine, dilated with 1% tropicamide, 
and placed on a heated mouse platform within the Ganzfeld dome of a Diagnosys LLC 
Espion Electrophysiology system (Lowell, MA). Mice were exposed to flashes of light 
ranging from -2 to 2.88 log cd*s/m2 with a flash frequency of 2000Hz. For flashes below 
-1 log cd*s/m2, the inter sweep delay was 10 sec, for the -1 log cd*s/m2 flash it was 
15sec, and for all remaining flashes, the delay was 20 sec. Oscillatory potentials (OPs) 
were measured at 3 log cd*s/m2 sampled at 2000Hz with an inter sweep delay of 15sec. 
Amplitudes were measured from trough to peak. 
 
Tissue collection 
Mice were euthanized by an overdose of avertin delivered via intraperitoneal 
injection and transcardially perfused with 4% paraformaldehyde (PFA, Electron 
Microscopy Sciences, Hatfield, PA) and phosphate buffered saline (PBS). The tissues 
were collected and stored in either 4% PFA (for immunohistochemistry) or 4% PFA with 
0.5% glutaraldehyde (Electron Microscopy Sciences, for resin).  
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Retina histology 
For histological analysis, eyecups were bisected to allow infiltration of Spurr’s 
resin (Electron Microscopy Sciences), sectioned at 1 micron-thickness on a Reichardt-
Jung Ultracut E microtome (Leica Microsystems, Vienna, Austria) and stained with 
toluidine blue. Representative images were collected on an Olympus Provis AX70 with 
a 60x oil objective lens. To quantify RPE damage, a grading scale was developed to 
classify the vacuoles: 1 (normal, very infrequent and small); 2 (small and infrequent); 3 
(small and frequent); 4 (large and infrequent); and 5 (large and frequent). The number 
of pyknotic nuclei in the outer nuclear layer (ONL) or inner nuclear layer (INL) was 
quantified within a single section of retina through the middle of each eye. A masked 
experimenter performed the imaging. 
 
Optic nerve histology 
Optic nerves were placed in 1% osmium tetroxide in 0.1 M cacodylate buffer, 
dehydrated in a graded ethanol series and embedded in Spurr’s resin (Electron 
Microscopy Sciences). Starting from the proximal (near the eye) end of the optic nerve, 
1 μm-thick sections were collected from a Reichert-Jung Ultracute E microtome and 
stained with 1% p-phenylenediamine in 50% methanol (Sigma-Aldrich). Sections were 
imaged on an Olympus Provis AX70 microscope using a 100x oil immersion objective 
lens. Imaging was performed in a masked fashion. 
 
 
 
 26 
Retina immunohistochemistry 
For immunohistochemistry, eyes were cryo-protected in 30% sucrose overnight 
at 4oC, embedded in Tissue Freezing Medium (Triangle Biomedical, Durham, NC) and 
then sectioned on a cryostat (Fisher, Pittsburgh, PA). Ten µm-thick sections were 
collected on 12 slides, with each slide containing representative sections from the entire 
eye. The sections were rinsed with PBS and incubated at room temperature in normal 
donkey serum at 1:20 in 0.1 M phosphate buffer with 0.5% bovine serum albumin and 
0.1% Triton X 100 (PBT) for 2 hours, followed by an overnight incubation at 4°C in a 
primary antibody in PBT. The sections were rinsed with PBS and incubated with a 
secondary antibody at a 1:200 dilution (Life Technologies, Grand Island, NY) for 2 hours 
at room temperature, rinsed with PBS and mounted in Vectashield Mounting medium 
with DAPI (Vector Laboratories, Burlingame, CA). Imaging was performed on a Nikon 
Eclipse epifluorescence microscope (Nikon, Melville, NY). The tissue was assessed in a 
masked fashion. 
 
TUNEL quantification 
Retina sections were labeled with the TUNEL Apoptosis Detection Kit adhering to 
the manufacturer’s protocol (Merck Millipore, Darmstadt, Germany) and mounted with 
Vectashield Mounting Medium with DAPI. TUNEL positive cells within the ONL, INL and 
GCL were counted and the lengths of the regions with TUNEL positive cells (affected 
regions) were measured using NIS Elements Advanced Research software (Nikon, 
Melville, NY). The total length of each retinal section with TUNEL positive cells (affected 
section) was also measured. In order to determine the percentage of the retina with cell 
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death, we measured and summed the lengths of all sections on the slide. Then, we 
divided the sum of affected region lengths by the total length of all sections and 
multiplied this value by 100, which yielded the percentage of retina with TUNEL positive 
cells. Quantification was performed in a masked fashion. 
 
Statistical analysis 
 The mean and standard error of the mean were calculated and presented for 
each data set. We performed both one-way and two-way ANOVAs with a Bonferroni’s 
post-hoc test on the visual acuity, ERG, and immunofluorescence quantification data 
using GraphPad Prism software (GraphPad, La Jolla, CA). We also used GraphPad 
Prism to calculate a student’s t-test to compare the means from the TUNEL and 
immunofluorescence quantification data. 
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Results  
Mild progressive trauma in the C57Bl/6J mouse 
Ocular blast trauma causes focal retinal detachments and outer segment 
disruption 
   
 After blast-exposure, the majority of the retina appeared normal (Figure 2.1A-B). 
However, we detected discrete areas of photoreceptor outer segment disruption (Figure 
2.1C-D) in 12% of eyes examined. Outer segment disruption occurred within the mid-
peripheral retina and mostly resolved by 1 month post-injury. We also detected retinal 
detachments (Figure 2.1E-F) in the mid-peripheral retina of 9% of eyes examined. The 
retinal detachments had a average height of 0.02 mm ± 0.03 and resolved by 1 month 
post-injury. 
Figure 2.1. Outer segment disruption and retinal detachments occur after blast 
exposure. B-scan images (A, C, E) show a normal retina (A), outer segment 
disruption post-blast (C, arrow) and a retinal detachment (E, arrow) post-blast. The 
green line on the fundus images (B, D, F) denote the location of the b-scan images 
and the red boxes denote the location of the pathology. 
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Ocular blast trauma damages the retina, RPE and optic nerve 
 
 Blast exposure induced focal damage in all eyes examined at 1 week and 1 
month post-blast. At 1 week post-injury (Figure 2.2C-D), the ONL contained an average 
of 2 ± 1 pyknotic nuclei and the INL contained an average of 2 ± 2. The number of 
pyknotic nuclei increased to 15 ± 12 in the ONL and 7 ± 4 in the INL at 1 month post-
injury (Figure 2.2E-F). In contrast, small RPE vacuoles occurred in all eyes examined at 
1 week post-injury (Figure 2.2C, insert), but rarely occurred at 1 month post-injury 
(Figure 2.2F, insert).    
 At 1 and 2 weeks post-injury, the optic nerves appeared similar to controls 
(Figure 2.3A). However, at 1 month post-injury (Figure 2.3, B, arrowheads), we detected 
a few degenerating axon profiles in 60% of nerves examined.  
 
  
Figure 2.2. Pyknotic nuclei and RPE vacuoles occur after blast exposure. 
Brightfield micrographs show a control (Ctrl) retina (A-B) and RPE (B, insert), RPE 
vacuoles at 1 week post-blast (D, arrowheads in insert) and pyknotic nuclei (E-F, 
arrows) at 1 month post-blast. GCL= ganglion cell layer, IPL= inner plexiform layer, 
INL= inner nuclear layer, OPL= outer plexiform layer, ONL= outer nuclear layer, IS= 
inner segments. 
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Ocular blast trauma elicits focal, delayed cell death in a subset of mice 
 All control, 3 day post-injury and 1-week post-injury retinal sections were TUNEL-
negative. At 1 month post-injury, we observed TUNEL-positive nuclei in 3 ± 2 % of the 
retina in 44% of eyes examined. Clusters of TUNEL-positive cells (defined as 5 or more 
TUNEL-positive nuclei in an 85 μm2 area) were primarily located in the mid-peripheral 
retina and occasionally in the central retina (Figure 2.4A-B,D). The clusters contained 
91 ± 49 TUNEL-positive cells, while the average number per mm total retina was 4 ± 3. 
The majority of TUNEL-positive nuclei were located in the ONL (92%), 8% were present 
in the INL and none were detected in the GCL. At 3 months post-injury, the percent 
retina containing TUNEL-positive cells increased to 10 ± 5 % in 83% of eyes examined. 
Similar to 1-month post-injury, clusters of TUNEL-positive nuclei were restricted to the 
mid-peripheral retina. The clusters contained 147 ± 38 TUNEL-positive cells, while the 
average per mm total retina was 53 ± 28. Unlike 1 month post-injury, TUNEL-positive 
Figure 2.3. Blast causes mild axonal degeneration. Brightfield 
micrographs show a healthy control optic nerve (A), a 1-month post-
injury optic nerve with degenerating axons (B, arrowheads) and a 3 
month optic nerve degenerating axons (C, arrowheads). 
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cells were present in all layers, with 77% in the ONL, 20% in the INL and 2% in the 
GCL. 
 
Blast induces nonapoptotic cell death 
At all time points post-blast, changes in RIP1 and RIP3 immunolabeling were 
restricted to 2-3 sections in the mid-peripheral and sometimes central retina, consistent 
with the localization and extent of TUNEL labeling. Antibody specificity was confirmed 
by immunolabeling of retinas from buffer or LPS-injected eyes (Figure 2.5B). At 3 days 
post-injury, there was a strong increase in RIP1 staining within the Müller glia and IPL 
Figure 2.4. Cell death post-blast is focal. Schematic of a flat-mounted retina, red 
bars indicate regions within retinal cross-sections that are TUNEL-positive (A). 
Epifluorescence micrograph of a TUNEL-positive mid-peripheral retinal cross-
section from a 1-month post-blast eye (B). The white box indicates a cluster of 
TUNEL-positive cells. Representative epifluoresence micrographs of retinas from 
control (C) or 1-month post-blast retinas labeled with TUNEL (red) and DAPI (blue). 
A cluster of TUNEL positive cells (D) and a TUNEL-negative area (E) from the 
same blast eye are shown. ON= optic nerve. 
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and a reduction in RIP3 labeling, as compared to controls (Figure 2.5A, C). At 1-month 
after blast, RIP1 labeling was slightly elevated while RIP3 labeling appeared to increase 
above control levels in the IPL and INL (Figure 2.5D). RIP3 labeling was also present in 
the ONL at 1 month post-blast (Figure 2.5D).  
No caspase-1 labeling was detected in control retinas (Figure 2.5E), but positive 
cells were detected in inner retinal neurons throughout the retinas of LPS-injected eyes 
(Figure 2.5F). A few caspase-1 labeled cells were present in the inner portion of the INL 
in 1 of 4 retinas at 3 days after blast. Positive cells were restricted to small regions, 
primarily in the mid-peripheral retina (Figure 2.5G). Caspase-1-positive cells were 
present throughout the ganglion cell layer (GCL) in 2 of 3 retinas at 1-week post-injury 
(Figure 2.5H). At 1-month post-injury, caspase-1-positive cells were present throughout 
the retina in the inner portion of the INL and occasionally in the GCL in 4 of 5 eyes 
(Figure 2.5I). The density of caspase-1-positive cells was much higher at 1 month than 
at 3 days or 1-week post-blast. However, at 3 months post-blast, caspase-1 positive 
cells were only occasionally observed in the GCL within the mid-peripheral retina. 
Double-labeling with choline acetyltransferase (ChAT) revealed colocalization in the 
majority of cells (Figure 2.5J). There was no colocalization of caspase-1 with tyrosine 
hydroxylase (TH), a marker of dopaminergic amacrine cells (Figure 2.5K).  
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Figure 2.5. Increased cell death pathway marker labeling after blast. Confocal 
micrographs of RIP1 (green) and RIP3 (red) immunolabeling in control (A), LPS-
injected (B) and affected areas (mid-periphery) of 3 day (C) and 1 week (D) post-blast 
retinas. Epifluorescence micrographs of caspase-1 immunolabeling (green) and DAPI 
(blue) in control (E), LPS-injected (F) and affected areas in 3 day (G) and 1 week (H) 
post-injury retinas. The entire retina was caspase-1 positive at 1 month post-blast (I). 
Epifluorescence micrographs of caspase-1 (green) and ChAT (red, J) or TH (red, K) 
double-labeling, arrows indicate caspase-1 positive nuclei. 
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Blast induces glial reactivity 
 
Glial fibrillary acidic protein (GFAP) labeling was similar to controls at all time 
points post-blast (Figure 2.6A-D). In the normal retina and in unaffected regions of the 
blast retinas, microglia had a typical ramified appearance and small cell body, and their 
localization was restricted to the inner retina (Figure 2.6E). Within small regions in the 
mid-peripheral and, occasionally, central retina of 3 day and 1 week post-blast retinas, 
the microglia exhibited shorter processes and larger cell bodies, indicative of a more 
reactive state (Figure 2.6F-G). At 1 month after blast, the microglia were amoeboid in 
appearance and were detected in the ONL (Figure 2.6H). 
Figure 2.6. Microglia, but not Müller glia, become reactive in response to blast in 
focal regions of the retina. Epifluorescence micrographs of GFAP immunolabeling 
(green) in control (A) and in 3 day (B), 1 week (C), and 1-month (D) post-blast 
retinas. Iba-1 immunolabeling (green) of microglia in control (E), 3 day (F), 1 week 
(G) and 1-month (H) post-blast retinas. Insets show higher magnification of 
representative microglia. DAPI labeled nuclei (blue). 
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Blast causes increased nitrotyrosine immunolabeling 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 2.7. Nitrotyrosine immunolabeling increases regionally after 
blast. Epifluorescence micrographs of control (A), LPS-injected (B) 
and mid-peripheral (C,E,G) and central (D,F,H) regions of 3 day 
(C,D), 1 week (E,F) and 1 month (G,H) post-blast retinas labeled 
with anti-nitrotyrosine (green) and DAPI (blue). 
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Light nitrotyrosine immunolabeling was present in the normal retina (Figure 2.7A) 
and labeling was brighter in retinas from LPS injected eyes, as expected (Figure 2.7B).  
At 3 days and 1 week post-injury, nitrotyrosine was elevated in the inner retina of the 
mid-peripheral (Figure 2.7C,E), but not central (Figure 2.7D,F), retina. The labeling 
appeared strongest in the inner portion of the INL (Figure 2.7E).  At 1 month post-blast, 
increased and diffuse immunolabeling was detected in the inner and outer retina and 
extended throughout the retina (Figure 2.7G-H).  
 
Ocular blast trauma induces transient visual deficits  
 
 
 
 
Within the first month post-injury, blast-exposed mice exhibited subtle, but 
statistically significant deficits in visual acuity when compared with sham mice (Figure 
2.8). Visual acuity in blast mice was significantly lower than sham mice at 1 week (0.33 
± 0.01 c/d vs. 0.40 ± 0.005 c/d), 2 weeks (0.36 ± 0.01 vs. 0.42 ± 0.01) and 3 weeks 
Figure 2.8. Blast induces visual acuity deficits. Visual acuity 
(mean ± SEM) was significantly reduced in blast-exposed mice 
at 1 week, 3 weeks and 1 month post-blast when compared to 
sham mice. *p<0.05 
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(0.31 ± 0.02 vs. 0.43 ± 0.01) post-blast. At 1 month post-injury, visual acuity improved in 
blast-exposed mice and was not significantly different from sham mice. In contrast, ERG 
a wave amplitudes (Figure 2.9A, C, E, G, I), b wave amplitudes (Figure 2.9B, D, F, H, J) 
and oscillatory potential amplitudes (Figure 2.10A-C) were not significantly different 
among blast and sham mice at any time point. 
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Figure 2.9. Ocular blast trauma does not affect ERG amplitudes. Both 
ERG amax values (A, C, E, G, I) and bmax values (B, D, F, H, J) were 
not significantly different between blast and sham animals. All values 
represent the mean ± SEM.  
 39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10. Blast exposure does not change oscillatory potential 
amplitudes. There were no differences between blast and sham mice in 
OP1 (A), OP2 (B) or OP3 (C). All values represent the mean ± SEM. 
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Severe trauma in the DBA/2J mouse 
Blast exposure damages the anterior pole 
 
Blast caused numerous anterior injuries that varied depending on time after blast 
(Table 1). Representative images of these pathologies after exposure to a 26psi blast 
are shown in Figure 1. The eyes appeared normal immediately after blast, but at 3 days 
(Figure 2.11B) significant pathologies were present including corneal edema (CE), 
hyphema, cataracts, and a few cases of corneal neovascularization (CNV). The 
incidence of CE after a 26psi blast remained high (86% of eye examined) out to 1 
month post-injury (Figure 2.11E). The incidence of hyphema peaked at 3 days after 
blast and was completely absent at 1 month post-blast. The incidence of hyphema at 3 
days after blast was 26%. In contrast, the number of eyes with CNV increased over time 
post-blast. At 3 days post-blast 17% of blast eyes exhibited signs of CNV. At 1 month, 
29% of blast eyes had CNV.  
 
 
Figure 2.11. Blast trauma injures the ocular surface. The majority of mice had 
calcium deposits in the cornea at baseline (A). Corneal edema and hyphema at 3 
days post-blast (B). Corneal edema and neovascularization at 1 week post-blast (C). 
A corneal growth with neovascularization and hyphema at 2 weeks post-blast (D). 
Corneal scarring and neovascularization at 1 month post-blast. Arrows indicate 
pathologies (E). 
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Table 1. DBA/2J gross pathology post-blast     
Type of Injury 
0 day 3 days 1 week 2 weeks 1 month 
(24)a 23 14 9 7 
Corneal abrasion 4 (17)b 1 (4) 0 0 0 
CE 0 16 (70) 5 (36) 5 (56) 6 (86) 
CNV 1 (4) 4 (17) 2 (14) 4 (44) 2 (29) 
Corneal scarring 0 2 (9) 1 (7) 4 (44) 5 (71) 
Hyphema 0 6 (26) 1 (7) 0 0 
Corneal growth 0 0 0 1 (11) 1 (14) 
Torn iris 0 0 0 1 (11) 2 (29) 
Traumatic cataract 0 8 (35) 1 (7) 1 (11) 1 (14) 
a Total number of eyes examined  
b Number of eyes with pathology (percentage) 
 
Ocular blast trauma causes retinal detachments 
  
 
 
 
 
 
Figure 2.12. Blast exposure damages the retina. At baseline, each layer of the 
retina appears normal in the b-scan image and the corresponding fundus image 
shows no signs of pathology (ONH: optic nerve head).  The green lines in the 
fundus images denote the location of the b-line scan images. An example of a 
retinal detachment after blast is shown. It appears as a dark area between the 
RPE and photoreceptors (arrow) and as a dark shadow in the mid-peripheral 
region of the retina fundus image (box). An example of retinal folds with 
corresponding retinal detachments (arrows; boxes) is shown. 
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The majority of post-blast retinas appeared normal at all time-points by OCT 
imaging, despite repositioning the eye multiple times during imaging to examine all 
retinal quadrants (Figure 2.12). When retinal detachments were detected they were 
primarily in the mid-peripheral retina and less frequently near the optic nerve head 
(ONH). At 3 days post-blast, 40% of eyes had a single retinal detachment that had an 
average height of 0.03mm ± 0.005 (Figure 2.12). At 1 week post-blast, only one eye had 
retinal detachments. The average height and number of the detachments at 1 week was 
0.05mm ± 0.03 and 6 per eye, respectively. One retina had a wavy appearance 
suggestive of epiretinal membranes and multiple retinal detachments (Figure 2.12). No 
detachments were observed at 2 weeks post-injury, but it is possible that detachments 
were missed during imaging. At 1 month, only the retina that appeared wavy at the 1 
week time point had retinal detachments, a total of 2, averaging 0.03mm ± 0.00 in 
height.  
 
Blast damages the retina, RPE and optic nerve 
In the normal RPE, there were no vacuoles or debris accumulation present 
(Figure 2.13A). In contrast, the RPE contained grade 5 vacuoles at 3 days post-blast in 
the majority of eyes (67%, Figure 2.13B). At 1 month after blast, the RPE vacuoles 
decreased in size to grade 2 (Figure 2.13C). At both time-points the RPE vacuoles were 
present throughout the retina. Subretinal debris, consisting of red blood cells and 
photoreceptor inner and outer segments, were detected in areas of retinal detachments 
at 3 days post-blast (Figure 2.13B), but appeared to resolve at 1 month post-blast 
(Figure 2.13C). 
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Figure 2.13. Neuronal death, RPE vacuoles and optic nerve degeneration occur after 
blast. Representative brightfield micrographs of the retina and RPE (A-C). 
Representative brightfield micrographs of the optic nerve (D-E). Control retina and RPE 
shows normal histology (A). A retinal detachment with subretinal debris is present in 
conjunction with pyknotic nuclei (arrows) in the ONL (B). The RPE contains grade 5 
vacuoles (arrowheads), and phagocytosed debris. There are fewer pyknotic nuclei 
(arrow) in the retina and the RPE vacuoles (arrowheads) are smaller in size at 1 month 
(1 mo) post-blast (C). The control optic nerve appears normal (D). At 1 month post-blast, 
the optic nerve contains degenerating axons with collapsed myelin (arrowheads) (E).  
The scale bars in the low and high magnification retina images are 50μm and the scale 
bar in the RPE images is 20μm. The scale bar for the optic nerve images is 5μm. 
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While much of the post-blast retina looked normal, clusters of pyknotic nuclei 
were observed at 3 days and 1 month (Figure 2.13B, C). The average number of 
pyknotic nuclei at 3 days post-blast was 14±10 in the ONL and 31±21 in the INL. At 1 
month post-blast, the average number of pyknotic nuclei decreased to 3±2 and 0±0 in 
the ONL and INL, respectively. Optic nerves from the first week post-injury (data not 
shown) looked the same as those from controls (Figure 2.13D). In contrast, 
degenerating axons with collapsed myelin were prevalent at 28 days post-injury (Figure 
2.13E). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14. Immune infiltrate appear after blast exposure. Immune infiltrate is 
present in the anterior chamber, including the cornea (A) and the aqueous 
humor near the ciliary body (B) and the aqueous humor near the cornea (C). An 
epiretinal membrane after blast (D, arrows). The epiretinal membranes are 
positive for C3d indicating that they are immune-mediated (E). The scale bar in 
(A) is 50μm and also applies to (B) and (D); the scale bar in (C) is 5μm; the 
scale bar in (E) is 25μm.  
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Immune infiltrate was present in a subset of eyes (33%) at both 3 days and 1 
month post-blast. Infiltrate was detected in both the anterior and posterior portions of 
the eye, including the cornea, aqueous humor, vitreous humor and surface of the retina 
(Figure 2.14A-C). Immune-mediated (C3d-positive) epiretinal membranes were 
occasionally detected in areas of retinal detachment (Figure 2.14D-E). 
 
Regional cell death occurs at multiple time points post-blast 
After blast, all retinas had areas with TUNEL-positive cells (i.e. affected areas) at 
3 days and 1 week post-injury, while 82% of retinas were TUNEL-positive at 1 month 
post-injury. Cell death was typically present in patches and not evenly distributed across 
the retina (Figure 2.15). These affected areas were primarily in the mid-peripheral 
retina, but occasionally were also detected in central retina (Figure 2.15A).  
The percentage of total retina containing TUNEL-positive cells, density of 
TUNEL-positive cells and retinal layer affected were quantified (Figure 2.16A). The 
majority of TUNEL-positive nuclei, 82%, 70% and 83%, were located in the ONL at 3 
days, 1 week and 1 month after injury, respectively (Figure 2.16A). A smaller 
percentage of TUNEL-positive cells, 12%, 27% and 16% were detected in the INL at 3 
days, 1 week and 1 month post-blast, respectively. Finally, 6%, 3% and 1% of all 
TUNEL-positive cells were in the GCL at 3 days, 1 week and 1 month post-injury, 
respectively. TUNEL positive nuclei were present in 13±8% of the retina at 3 days post-
injury, 2±0.2% at 1 week post-blast, and 5±1% of the retina at 1 month post-injury 
(Figure 2.16B). When calculated in terms of total retina length, the density of TUNEL 
was very low, but retained the same trend of higher levels at 3 days as compared to 1 
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month. The number of TUNEL-positive nuclei per mm total retina was 15±9, 0.1±0.1, 
and 11±4 at 3 days, 1 week and 1 month post-blast (Figure 2.16C). Within the affected 
regions, the density of TUNEL-positive cells was 87±44, 10±3, and 215±57 nuclei per 
mm retina at 3 days, 1 week and 1 month after blast, respectively (Figure 2.16D). These 
results demonstrate that the area occupied by TUNEL-positive cells decreases over 
time, but the density of TUNEL-positive cells within affected areas increases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15. Cell death occurs in small, focal areas after blast. A schematic 
representing an enface view of the retina showing the average number and 
distribution of affected (i.e. TUNEL positive) areas (red bars) detected in 
retinal cross-sections collected in serial through the 3 day post-blast eye (A). 
Montage of low magnification epifluorescence micrographs of a 3 day post-
blast retina (B). White boxes indicate affected areas (scale bar is 250μm). 
Higher magnification epifluorescence micrographs of TUNEL (red) and DAPI 
(blue) in a control retina (C), and affected (D) and unaffected (E) regions of the 
retina shown in (B). The scale bar in (C) represents 50μm and also applies to 
(D) and (E). 
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Figure 2.16. Cell death occurs in two waves after blast. Pie chart showing the 
distribution of TUNEL positive cells through the retinal layers after blast (A). The 
percentage of total retina containing TUNEL-positive cells at each time point (B). The 
average number of TUNEL positive cells per mm total retina after blast (C). The 
average number of TUNEL positive cells per mm within the affected areas after blast 
(D). Error bars represent SEM for each time point. 
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Blast induces changes in cell death pathway markers 
Labeling for markers for necroptosis (programmed necrosis; RIP1 and RIP3) was 
increased after blast. In the normal retina, RIP1 localized to the Müller glia, the IPL and 
the INL, with some light staining in the OPL (Figure 2.17A). Light RIP3 staining in the 
normal retina was restricted to the GCL, IPL and INL (Figure 2.17A). At 3 days post-
injury, RIP1 increased in the ONL, INL, and Müller glia, while RIP3 increased in the 
Figure 2.17. Changes in cell death markers after blast suggest a non-apoptotic 
mode of cell death. Confocal micrographs of retinas immunolabeled for RIP1 
(green) and RIP3 (red; scale bar in A-C is 30μm). Epifluorescence micrographs of 
Caspase-1 (green) immunolabeling and DAPI (blue; scale in D-F is bar is 25μm). 
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ONL, INL, IPL, and GCL (Figure 2.17B). As cell death progressed at 1 month post-blast, 
RIP1 remained elevated in the ONL and INL, while RIP3 remained elevated in the IPL 
and maintained some light labeling in the ONL (Figure 2.17C).  
Caspase-1 was present within the INL and GCL throughout the control retinas 
(Figure 2.17D).  At 3 days post-injury, only one third of retinas exhibited caspase-1 
positive cells in the INL and GCL (Figure 2.17E). At 1 month after blast, all retinas were 
caspase-1 negative (Figure 2.17F). Immunolabeling with anti-ChAT in the DBA/2J 
showed that starburst amacrine cells were still present at 1 month post-blast (data not 
shown). 
 
Protein nitration increases in the retina after blast  
 In the normal retina, nitrotyrosine immunolabeling was light and restricted to the 
inner retina (Figure 2.18A). Three days after blast, immunolabeling was greatly 
increased throughout both the inner and outer retina (Figure 2.18B). The 
immunolabeling seemed less increased, but still elevated in both the inner and outer 
retina at 1 month post-blast (Figure 2.18C). 
 
Glial reactivity increases in the retina after blast 
In the normal retina, GFAP immunolabeling was restricted to the Müller glia 
endfeet and astrocytes (Figure 2.19A). At both 3 days and 1 month post-injury, GFAP 
immunolabeling was increased in the Müller cell processes (Figure 2.19B-C). In age-
matched control retinas, IBA-1 immunolabeling showed that microglia were  
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Figure 2.18. Nitrotyrosine increases following blast. Representative 
epifluorescence micrographs of control (A), 3 days (B) and 1 month (C) 
post-blast retinas immunolabeled for nitrotyrosine (green) and labeled 
with DAPI (blue). Scale bar is 25μm and applies to all images. 
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restricted to the inner retina and were fairly low in density (Figure 2.19D). Microglia were 
more prevalent after blast when compared to controls beginning at 3 days and 1 month 
post-blast (Figure 2.19E-F). Reactive microglia, which are amoeboid in appearance, 
were detected (Figure 2.19E-F, inserts).  
 
 
 
Ocular blast trauma causes visual deficits  
 The ERG a wave amplitude was diminished to approximately 40% of baseline at 
1 week post-blast based on an average of the responses at each light intensity (Figure 
2.20A). At 2 weeks post-blast, a statistically significant decrease was still present, but 
the level of decrease was less substantial at an average of 55% of baseline. At 1 month 
Figure 2.19. Both Müller glia and microglia are reactive after injury. Representative 
epifluorescence micrographs of control (A), 3 days (B) and 1 month (C) post-blast 
retinas immunolabeled for GFAP (green). Representative epifluorescence 
micrographs of  control (D), 3 days (E) and 1 month (F) post-blast retinas 
immunolabeled for Iba1 (green). Higher magnification images of representative 
microglia are present in inserts. Scale bar is 25μm and applies to all images; DAPI is 
shown in blue. 
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post-blast, the a wave amplitude was similar to baseline at the brightest flash, but was 
still reduced at the other flash intensities (Figure 2.20A). The average deficit from 
baseline at the lower light intensities was 63% at 1 month post-blast.  
The ERG b wave amplitude was similar to baseline at the brightest light intensity 
at all time points post-blast (Figure 2.20B). However, at all other light intensities, there 
was a deficit averaging 52% below baseline at 1 week post-blast, 74% of baseline at 2 
weeks post-blast, and 48% of baseline at 1 month post-blast. The decrease in the b 
wave amplitude at 1 week post-blast seems to correspond to the decrease in the a 
wave amplitude at this time point (Figure 2.20B). In contrast, the decrease in the b wave 
amplitude, particularly at 0 and 1 log cd*s/m2 (p<0.01) at 1 month post-blast was greater 
than at earlier time-points despite a recovery of a wave.  
The OPs were also affected after blast (Figure 2.20C). OP1 was diminished at all 
time-points after blast (p<0.01). OP2 was significantly lower than baseline at both 1 
week and 1 month (p<0.01). OP3 appeared lower than baseline, but only reached 
statistical significance at 1 week post-blast (p<0.01). A significant decline in visual acuity 
was observed at 3 days (0.34 ± 0.07, p<0.05) and 1 month (0.09±0.02, p<0.01) post-
blast (Figure 2.20D).  
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Figure 2.20. Blast causes early and late visual deficits. Bar graph of the ERG 
amax over light intensity (A). Bar graph of ERG bmax over light intensity (B). Bar 
graph of the oscillatory potential (OP) peak amplitude at each time point (C). 
Photopic spatial threshold (i.e. visual acuity) is significantly decreased at 3 days 
and 1 month post-blast (D). *p<0.05. Error bars represent SEM for each graph. 
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Moderate trauma in the Balb/cJ mouse 
 
Blast induces anterior pathologies 
 
  Immediately post-blast, we observed corneal edema, corneal neovascularization 
(CNV) and traumatic cataracts in 15% of the mice (Table 2, Figure 2.20 A-C). The 
incidence of pathology increased over time post-blast. At 1 month post-blast, the 
hyphemas and corneal abrasions resolved, but corneal edema, CNV, corneal scarring 
and traumatic cataract remained in 42%, 37%, 42% and 10% of eyes, respectively. At 2 
months post-blast, only corneal edema and CNV remained, which were present in 
100% and 60% of eyes, respectively. Due to the prevalence of anterior pathologies, we 
did not assess visual function. 
 
 
 
 
Figure 2.21. Blast causes anterior pathologies. Representative images of 
common pathologies detected after blast: corneal edema (A), cataract and 
corneal neovascularization (B), cataract, corneal edema, and hyphema (B). 
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Type of Injury 0d (72)a 3d (67) 
1 wk 
(46) 
2 wk 
(9) 
1 mo 
(19) 
2 mo 
(5) 
Corneal abrasions 0 6 (8) 2 (4) 5 (55) 0 0 
Corneal edema 9 (10)b 32 (42) 
36 
(78) 4 (44) 8 (42) 
5 
(100) 
CNV 2 (2) 11 (14) 
11 
(24) 5 (55) 7 (37) 
3 
(60) 
Hyphema 0 0 3 (6) 3 (33) 0 0 
Corneal scarring 0 0  5 (11) 0 8 (42) 0 
Traumatic Cataract 3 (3) 9 (12) 
10 
(22) 2 (22) 2 (10) 0 
aTotal number of eyes examined 
     bNumber of eyes with pathology (percentage); d=days, 
wk=week, mo=month 
     
 
Blast exposure causes retinal detachments 
 Most retinas appeared similar to non-blast controls (Figure 2.22A). Large retinal 
detachments were detected in 37% of blast-exposed eyes (Figure 2.22B-C). The 
appearance of the retinal detachments with high and low areas is suggestive of a fusion 
of many small retinal detachments (Figure 2.22B-C). The retinal detachments were 
present in the mid-peripheral retina, which appeared as mottled and/or darkened areas 
in the fundus images (Figure 2.22D-E, arrows).  
Figure 2.22. Blast induces large retinal detachments. OCT B-line scans of retinas 
from an uninjured eye (A) and a 3d post-blast eye (B). Three-dimensional 
reconstruction of a stack of OCT B-line scans from a post-blast eye showing multiple 
retinal detachments (C). En face OCT images of post-blast retinas showing the 
peripheral localization and grouping of the retinal detachments (D-E).  
Table 2. The incidence of gross pathology in the Balb/cJ 
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Ocular blast trauma damages the retina and RPE 
 
Naïve control eyes had healthy retinas and RPE (Figure 2.23A). At 1 week post-
blast, small, infrequent vacuoles (grade 2 ± 0.4) were present in the RPE and the retina 
contained an average of 11 ± 2 pyknotic nuclei in the ONL and 1±0.6 pyknotic nuclei in 
the INL (Figure 2.23B). At 1 month post-blast, the average grade for RPE vacuoles was 
3 ± 0.7, indicative of small, frequent vacuolization. The ONL and INL at this time-point 
contained 14 ± 9 and 14 ± 13 pyknotic nuclei, respectively. At 60 days post-blast, RPE 
vacuolization remained high (grade 3 ± 0.6; Figure 2.23C). Pyknotic nuclei were also 
still detected in the ONL (3 ± 0.4), and INL (2 ± 0.4) even at 60 days post-blast (Figure 
2.23D). 
 
 
 
Figure 2.23. Blast injures the retina and RPE. Representative brightfield micrographs 
of retina (A-B) and RPE (C-D) from uninjured (A), 1 week post-blast (B) and 2 months 
post-blast (C-D) mice. Arrows indicate pyknotic nuclei. Arrowheads in C indicate RPE 
vacuoles. Scale bar in A represents 25μm and applies to all images. 
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Optic nerve degeneration occurs after blast  
 
In the optic nerves from non-blast mice, the axons were tightly ensheathed by 
myelin and the axoplasm was clear (Figure 2.24A). In contrast at 1 week, 1 month and 2 
months post-blast, the optic nerves contained degenerating axon profiles, marked by 
collapsed and thickened myelin (Figure 2.24B-D, arrows). 
 
Figure 2.24. Blast trauma causes optic nerve degeneration. Representative 
brightfield micrographs of optic nerves from uninjured (A), 1 week post-blast (B), 1 
month post-blast (C) and 2 months post-blast (D) mice. Arrows indicate degenerating 
axons. Scale bar represents 50m and applies to all images. 
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Blast exposure causes retinal cell death 
  
All non-blast retinas were TUNEL-negative (Figure 2.25A). In contrast, at 3 days 
post-blast, 16 ± 4% of the retina was TUNEL-positive (data not shown). At 1week post-
blast, 51 ± 12% of the retina contained TUNEL-positive cells (Figure 2.25B), which was 
significantly higher than the amount of cell death observed at 3 days post-blast (Figure 
2.25D). Cell death persisted at 1 month post-blast, with 14 ± 4% of the retina containing 
Figure 2.25. Ocular blast trauma induces cell death in the retina. 
Representative fluorescence micrographs of TUNEL in retina (A-C) from 
uninjured (A), 1 week post-blast (B) and 1 month post-blast (C) mice. TUNEL 
(red), DAPI (blue). Scale bar represents 50m. Box and whisker plot of 
retinal TUNEL quantification at 3 days and 1 week post-blast, *p<0.05. 
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TUNEL-positive nuclei (Figure 2.25C). At all time points, the majority of the TUNEL-
positive nuclei were located in the ONL. 
 
Neuroinflammation occurs in first week post-trauma 
  
 
Figure 2.26. Blast induces mild neuroinflammation. Representative fluorescence 
micrographs of GFAP immunolabeling in retinas from uninjured (A), 1 week post-
blast (B) and 1 month post-blast retinas (C). Anti-GFAP (green), DAPI (blue). 
Scale bar represents 50m and applies to all images. Bar graphs of cytokines 
altered or trending towards an increase after injury (D-E). *p<0.05, #p<0.0001; 
S=sham, T=trauma 
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In the retinas from non-blast mice, GFAP immunolabeling was present in the 
Müller glia endfeet and astrocytes (Figure 2.26A). In contrast, GFAP immunolabeling 
extended into the Müller glial process at 3d (data not shown), 1 week (Figure 2.26B) 
and 1 month post-blast (Figure 2.26C). These changes were uniform throughout the 
retina at all time points post-injury. We then assessed if the glial cell hypertrophy also 
correlated with increased levels of pro-inflammatory cytokines and chemokines (Figure 
2.26D-E).  A statistically significant increase was detected for KC (i.e. chemokine C-X-C 
motif ligand-1) at 3 days post-blast as compared to the 3 days post-sham (p<0.05; 
Figure 2.26D). Levels of interleukin 1 alpha (IL-1, interferon-gamma-inducible protein 
10 (IP-10 or chemokine C-X-C motif ligand-10), interleukin 10 (IL-10) appeared equally 
increased at both 3 days and 1 week after trauma, but were not significantly different 
from matched sham controls. Due to high variability and small sample size, we 
combined the 3 days and 1 week groups together to create the all trauma and all sham 
groups. A statistically significant increase was detected in both IP-10 (Figure 2.26D, 
p<0.0001) and IL-10 (Figure 2.26E, p<0.05) in the all trauma group as compared to all 
sham. Monocyte chemoattractant protein-1 (MCP-1 or chemokine C-C motif ligand-2) 
trended higher at 3 days, but not 1 week after trauma (Figure 2.26D). 
 
Reactive oxygen species (ROS) are increased after trauma 
 Using the in vivo fluorescent markers CM-H2DCFDA and DHE, an increase in 
ROS was detected at 1 week post-blast as compared to shams (Figure 2.27A-D). No 
fluorescence was detected in sham eyes after injection of either probe (Figure 2.27A,C). 
In contrast, fluorescence for both markers was present after trauma (Figure 2.27B,D).  
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The eyes with the greatest amount of fluorescence are shown. In particular, levels of 
superoxide (as measured by DHE) and ROS (as measured by CM-H2DCFDA) appear to 
be elevated at 1 week post-blast (Figure 2.27B,D). Nitrotyrosine immunolabeling was 
also significantly increased in the inner, but not outer, retina at 1 week post-trauma. 
 
Figure 2.27. Blast induces oxidative stress. In vivo images of CM-H2DCFDA 
fluorescence, a general indicator of reactive oxygen species, in sham (A) and 1 week 
post-blast eyes (B). In vivo images of DHE fluorescence, an indicator of superoxide, 
in sham (C) and 1 week post-blast eyes (D). Representative epifluorescence 
micrographs of nitrotyrosine immunolabeling (green) of sham (E) and 7d post-trauma 
(F) retinas double labeled with DAPI (blue). Bar graph of nitrotyrosine 
immunofluorescence quantification in the inner (G) and outer (H) retina. **p<0.01. 
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Mild blunt trauma in the contralateral eye after blast  
 
Blunt trauma causes anterior injuries in the D2 mouse 
  
Figure 2.28. The ocular surface is injured in the D2 contralateral eye. Calcium deposits are 
common in the D2 eye prior to injury (A). Hyphema, CE and cataracts occur at 3 days post-
injury (B). CE and calcium deposits occur at 1 week post-injury (C). CE, CNV and calcium 
deposits at 2 weeks post-injury (D). A corneal scar and CNV at 1 month post-injury (E). 
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As in the blast-exposed eye, no anterior pathology was detected in the 
contralateral Bl/6 eye (Bricker-Anthony et al., 2014b). In the contralateral D2 eye, 
corneal edema (CE) occurred in 52% of eyes at 3 days post-injury (Figure 2.28B) and 
remained in 43% of mice at 1 month (Figure 2.28E). Cataracts were observed in 30% of 
D2 contralateral eyes at both 3 days and 1 month post-injury (Figure 2.28B,E). Corneal 
neovascularization (CNV) and corneal calcifications became more prevalent over time. 
CNV was detected in 44% and 29% of eyes at 2 weeks and 1 month post-injury, 
respectively (Figure 2.28D-E). Corneal scarring was detected in 33% and 43% of eyes 
at 2 weeks and 1 month post-injury, respectively (Figure 2.28D-E).  
 
Ocular trauma causes retinal detachments 
In the Bl/6 mouse, disruption of the outer segments (as determined by a bright 
area on the fundus, (Figure 2.29C) was observed in 25% of contralateral retinae within 
the mid-periphery at 1 week and in 8% of contralateral retinae at 2 weeks and 1 month 
post-injury. Retinal detachments were detected in 13% and 15% of Bl/6 contralateral 
retinae at 1 week and 2 weeks post-injury, respectively (Figure 2.29C). This decreased 
to 8% of retinas at 1 month post-injury. Up to eight retinal detachments per eye were 
detected and the average height of the retinal detachments was 0.02±0.003mm at all 
time points.  
In the D2 mice at 2 weeks post-injury, an average of 13 retinal detachments per 
eye were detected in 17% of contralateral eyes (Figure 2.29D). The average height of 
the retinal detachments was 0.04±0.07mm. No retinal detachments were detected at 1 
week or 1 month post-injury.  
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Figure 2.29. Blast induces retinal detachments in both Bl/6 and D2 
contralateral eyes. Both Bl/6 (A) and D2 (B) retinas appear normal at 
baseline in both the b-scan and fundus images. The green line in the 
fundus image denotes the location of the b-scan. A retinal detachment 
(arrow) is present at 1 week post-injury in the Bl/6 retina  and is visible on 
the fundus image as a small, round dark area (C, red box). Areas of outer 
segment disruption appear as white, patchy areas on the fundus image 
(C, arrows). Retinal detachments in a D2 retina at 2 weeks post-injury (D, 
arrows, red boxes). 
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Ocular trauma doesn’t displace the lens 
In order to detect lens displacement, we imaged and measured the depth of the 
anterior chamber in a subset of mice (n=16; D2) at baseline and several hours post-
injury. There was no statistically significant difference between baseline chamber depth 
(0.37mm±0.00) and post-injury chamber depth (0.38±0.01mm) in the contralateral eyes. 
 
Trauma damages both the retina and RPE 
Figure 2.30. Focal retinal and RPE damage occurs in the contralateral eyes of 
both strains post-blast. Both Bl/6 (A) and D2 (B) control retina and RPE have no 
pyknotic nuclei and no RPE vacuoles. Both pyknotic nuclei (arrows) and RPE 
vacuoles (arrowheads) occur at 1 week post-injury in the Bl/6 (C) and at 3 days 
post-injury the D2 (D). At 1 month post-injury, pyknotic nuclei (arrow) and RPE 
vacuoles (arrowhead) are rare in the Bl/6 (E), while the D2 eyes contains pyknotic 
nuclei and smaller RPE vacuoles (F). The scale bars are: 50µm in the low 
magnification retina image; 25µm in the high magnification retina image; and 5µm 
in the RPE image. 
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 Controls for both strains had healthy RPE with no vacuoles and retinas lacked 
pyknotic nuclei or other pathology (Figure 2.30A-B). Due to the lack of pathology at 3 
days post-injury, Bl/6 retinas were examined at 1 week and 1 month post-injury. D2 
retinas were examined at 3 days and 1 month post-injury. While much of the retina 
looked normal, focal damage was detected in both strains. 
Pyknotic nuclei were present in Bl/6 contralateral eyes post-blast (Figure 2.30C, 
E). The average number of pyknotic nuclei at 1 week post-injury was 16±6 in the ONL 
and 21±7 in the INL. At 1 month post-injury, the average number of pyknotic nuclei 
within contralateral retinae decreased to 3±2 in the ONL and 1±1 in the INL. Grade 3 
vacuoles were observed in all contralateral eyes at 1 week post-injury (Figure 2.30C). 
By 1 month post-injury, the RPE was normal (grade 1) in all of the eyes examined 
(Figure 2.30E).   
In the D2 mice, pyknotic nuclei were also observed in contralateral retinae post-
injury (Figure 2.30D, F). At 3 days post-injury, the average number of pyknotic nuclei 
was 10±3 and 13±1 in the ONL and INL, respectively. At 1 month post-injury, the 
average number of pyknotic nuclei in the contralateral retinae was 12±1 in the ONL and 
4±2 in the INL. The RPE of contralateral D2 eyes contained grade 5 RPE vacuoles at 3 
days post-injury in 67% of eyes (Figure 2.30D). At 1 month post-injury, 60% of 
contralateral eyes contained RPE vacuoles, ranging from grade 2-4 (Figure 2.30F).  
 
Delayed cell death occurs after trauma in both strains 
In the Bl/6 contralateral eyes, cell death was not detected until 1 week post-injury 
and was limited to small patches in the mid-peripheral and occasionally central retina 
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(Figure 2.30C, E). The majority of the TUNEL-positive nuclei were located in the ONL 
(Figure 2.30G). TUNEL-positive cells were present in only 4±2% and 3±1% of the 
retina, at 1 week and 1 month post-injury, respectively (Figure 2.32A). The density of 
cell death throughout the entire retina was also low at 1 week and 1 month post-injury 
with 18±11 cells/mm retina and 11±4 cells/mm retina, respectively (Figure 2.32B). 
Within areas of cell death (affected regions, Figure 2.31E, 2.32A), the density of 
TUNEL-positive nuclei was 383±179 cells/mm retina at 1 week and 373±77 cells/mm 
retina at 1 month post-injury (Figure 2.32C). The comparable density and percent retina 
affected at both time points suggests ongoing cell death in the Bl/6 from 1 week to 1 
month post-trauma. 
The onset of cell death also occurred at 1 week post-injury in the D2 and was 
limited to small patches in the mid-peripheral and central retina (Figure 2.31D, F). Like 
the Bl/6, many TUNEL-positive nuclei were present in the ONL (Figure 2.31H). At 1 
week post-injury, 19±8% of the retina contained TUNEL-positive cells (Figure 2.32A). At 
1 month post-injury, the percentage of TUNEL-positive contralateral retina decreased to 
3±2% (Figure 2.32A). The density of TUNEL-positive nuclei throughout the entire retina 
of the D2 was low; 49±30 cells/mm retina at 1 week post-injury, decreasing to 12±8 
cells/mm retina at 28 dpi (Figure 2.32B). The density of TUNEL-positive nuclei within 
the affected regions of the D2 retina was 475±81 cells/mm retina at 1 week post-injury 
and 212±135 cells/mm retina at 1 month (Figure 2.32C). The decrease in both the 
percent retina affected and the density of cell death in those areas at 1 month post-
injury suggests that in the D2 there is a peak of cell death at 1 week that decreases at 1 
month post-injury. 
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Figure 2.31. Cell death occurs in focal regions after blast in both strains. 
Epifluorescence micrographs of retinal cross-sections from control Bl/6 (A), 1 
week post-injury Bl/6 (C), control D2 (B) and 1 week post-injury D2 (D). TUNEL 
(red), DAPI (blue). The scale bar in (E) is 50µm and applies to all micrographs. 
Schematics illustrating the locations of TUNEL-positive retinal cross-sections in 
relation to the optic nerve (ON) in the Bl/6 (E) and the D2 (F). Pie charts showing 
the percentage of TUNEL-positive cells in each retinal layer in the Bl/6 (G) and D2 
(G). 
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Figure 2.32. Cell death occurs at 1 week and 1 month post-injury in both 
strains. Bar graphs show the percentage of retina containing TUNEL-positive 
cells (A), the density of TUNEL-positive cells in the retina (B), and the density of 
TUNEL-positive cells within the affected region (C). The bar graphs represent 
the average ± SEM for each time point and strain. 
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Necroptotic and pyroptotic pathways are activated following injury in both strains 
In both Bl/6 and D2 control retinae, RIP1 localized to the Müller glia, the INL and 
the IPL, with some light staining in the OPL (Figure 2.33A-B). RIP3 immunolabeling was 
present in the IPL and INL in control retinas from both Bl/6 and D2 mice (Figure 2.33A-
B). At 3 days post-injury, RIP1 staining increased within the Müller glia and IPL, but 
there were no changes in RIP3 labeling (Figure 2.33C). The increased labeling was 
limited to 3-4 sections from each eye, indicative of focal damage.  At 1 month post-
injury, no increased RIP1 labeling was present, but RIP3 labeling was increased in the 
ONL, IPL and GCL (Figure 2.33E). Again, these changes were limited to 3-4 sections in 
each eye.  
In the D2 retina, both RIP1 and RIP3 labeling was similar to controls throughout 
the eye at 3 days post-injury (Figure 2.33D). At 28 dpi, RIP1 staining was brighter in the 
ONL and INL, while RIP3 staining was brighter in the ONL, INL, IPL, and GCL (Figure 
2.33F). Similar to the Bl/6, these changes were limited to 3-4 sections in each eye. 
Caspase-1 immunolabeling was absent in control and 3 day post-injury Bl/6 
retinas (Figure 2.34A, B). At 1 month post-injury, 75% of contralateral C57Bl/6J retinae 
contained caspase-1 positive cells at the inner edge of the INL and in the GCL (Figure 
2.34C). The caspase-1 positive cells were present throughout the retina and the 
labeling did not appear different between central (Figure 2.34D) and mid-peripheral 
retina (Figure 2.34E). In contrast, caspase-1 positive nuclei were present within the INL 
and GCL of control D2 retinas (Figure 2.35A). However, at both 3 days and 1 month 
post-injury in the D2 retinae, no caspase-1 positive nuclei were detected (Figure 2.35B-
C). 
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Figure 2.33. RIP1 and RIP3 immunolabeling increases after blast in both the Bl/6 
and D2. Confocal micrographs of retinas from control Bl/6 (A), control D2 (B), 3 
day post-injury Bl/6 (C), 3 day post-injury D2 (D), 1 month post-injury Bl/6 (E) and 
1 month post-injury D2 (F). RIP1 is pictured in green and RIP3 is in red. The scale 
bar in (A) is 50µm. 
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Figure 2.34. Caspase-1 immunolabeling increases at 1 month post-injury in the Bl/6 
retina. Epifluorescence micrographs of retinas from control (A), 3 days post-injury (B) 
and 1 month post-injury (C) eyes labeled with anti-caspase-1 (green) and DAPI 
(blue). Caspase-1 immunolabeling at 1 month post-injury is the same in both central 
(D) and mid-peripheral (E) retina. The scale bar is 50µm in (A-C) and 250µm in (D-
E). 
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Figure 2.35. Caspase-1 immunolabeling is reduced after trauma in the D2. 
Representative epifluorescence micrographs of control (A), 3 days post-
injury (B) and 1 month post-injury (C) retinas immunolabeled for caspase-
1. The scale bar in (A) is 50µm and applies to all micrographs. 
 74 
Glial reactivity occurs after trauma  
 Similar to the blast-exposed Bl/6 retina, GFAP immunolabeling was restricted to 
the astrocytes and Müller glia endfeet at all time points post-injury (Figure 2.36A-D). In 
contrast, GFAP immunolabeling extended up the Müller cell processes in the D2 retinas 
(Figure 2.37B-C). At 3 days post-injury, the GFAP positive processes were detected 
uniformly across the retina (Figure 2.37B). At 1 week post-injury, GFAP positive 
processes were only detected in small patches in the mid-peripheral and central retina 
(Figure 2.37C). Increased GFAP immunolabeling was not detected in any region of the 
retina at 1 month post-injury (Figure 2.37D). 
In the normal Bl/6 and D2 retina, microglia had small somas with dendritic 
ramifications and were present only in the inner retina (Figure 2.38A-B). In the Bl/6 
retina, all changes in microglial morphology after injury were limited to focal areas (e.g. 
1-2 sections from each eye). At 3 days post-injury, reactive microglia (enlarged somas 
with fewer shorter processes) were observed in the ONL and INL and microglial 
processes extended into the ONL (Figure 2.38C). At 1 week and 1 month post-injury, 
there were no reactive microglial somas in the ONL, but a few reactive microglia were 
present in the INL and occasional processes were detected in the ONL (Figure 2.38E, 
G).  
Reactive microglia were commonly observed throughout the D2 retina at 3 days 
post-injury (Figure 2.38D). Macrophages were also occasionally observed in the outer 
segment layer of the photoreceptors in areas of retinal detachment (Figure 2.38D). At 1 
week and 1 month post-injury, microglial reactivity was limited to focal areas of the inner 
retina in the mid-periphery and occasionally the central retina (Figure 2.38F, H). 
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Figure 2.36. GFAP immunolabeling remains restricted to the astrocytes 
and Müller glia endfeet in the Bl/6 after injury. Representative 
epifluorescence micrographs of control (A), 3 days post-injury (B), 1 week 
post-injury (C) and 1 month post-injury (D) retinas immunolabeled for 
GFAP. The scale bar in (A) is 50µm and applies to all micrographs. 
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Figure 2.37. GFAP labeling is increased in the Müller glia of D2 eyes at 3 
days and 1 week post-injury. Low and high magnification epifluorescence 
micrographs of control (A), 3 days post-injury (B), 1 week post-injury and 1 
month post-injury (D) retinas labeled with GFAP (green) and DAPI (blue). The 
scale bar for the high magnification micrographs is 50µm. The scale bar for 
the low magnification micrographs is 250µm. 
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Figure 2.38. Reactive microglia are present in Bl/6 and D2 retinas after 
injury. Low magnification epifluorescence micrographs and high 
magnification micrographs (insets) of control (A-B), 3 days post-injury 
(C-D), 1 week post-injury (E-F) and 1 month post-injury (G-H) retinas 
immunolabeled with Iba1 (green) and DAPI (blue). The scale bar for the 
low magnification micrographs is 50µm. The scale bar for the inserts is 
10µm. 
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Figure 2.39. Nitrotyrosine immunolabeling increases after blast in the retina of 
both strains. Epifluorescence micrographs of control (A-B), 3 days (C-D), 1 
week (E-F) and 1 month post-injury (G-H) retinal cross-sections labeled for 
nitrotyrosine (green) and DAPI (blue). The scale bar is 50µm and applies to all 
micrographs. 
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Protein nitration increases in the retina after blast  
In the Bl/6 mouse, all eyes exhibited a slight increase in nitrotyrosine 
immunolabeling in the inner retina at 3 days and 1 week post-injury when compared to 
controls (Figure 2.39C, E). Changes in nitrotyrosine immunolabeling were limited to 
focal areas within both the mid-peripheral and central retina. At 1 month post-injury, 
there was nitrotyrosine immunolabeling in the outer retina (absent in the normal retina), 
in addition to more labeling in the inner retina (Figure 2.39G). The changes in labeling 
were uniform across the retina.  
 At 3 days post-injury in the D2 mouse, nitrotyrosine immunolabeling was greatly 
increased in the inner retina of all eyes with no apparent regional differences when 
compared to controls (Figure 2.39D). Labeling remained elevated throughout the inner 
retina of all eyes 1 week and 1 month post-injury, with no apparent regional differences 
(Figure 2.39F, H).  
 
Ocular trauma causes visual deficits  
 Both strains showed decreased OKN scores (i.e. visual acuity) in the 
contralateral eye post-blast (Figure 2.40A-B). In the Bl/6 mouse, OKN scores were only 
significantly different from baseline (0.41±0.01 c/d) at 1 week post-injury (0.30±0.04 c/d, 
p<0.01, Figure 2.40A). In the D2 mice, OKN scores first declined significantly at 3 days 
post-injury (0.40±0.06 c/d, p<0.01) when compared to baseline values (0.60±0.03 c/d, 
Figure 2.40B). OKN scores were also significantly different from baseline at 2 weeks 
and 1 month post-injury (0.25±0.06 and 0.07±0.03 c/d, p<0.01, respectively). 
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There were no significant changes in the ERG amax, bmax or oscillatory potentials 
at any time point assessed in the Bl/6 eye after injury (Figure 2.41A, C, E). However, 
there were significant reductions in both amax and bmax in the D2 after blast when 
compared to baseline values (Figure 2.41B, D). At 1 week post-injury, the amax was 
significantly lower than baseline at light intensities that correlate with daytime light 
levels. At 0 log cd*s/m2 the amax was decreased by 39% from 135.7 ± 9.6 μV at baseline 
to 82.5 ± 14.2 μV, p<0.01 (Figure 2.41B). At 1 log cd*s/m2 the amax was decreased by 
29% from 194.3 ± 12.2 μV to 137.9 ± 20.2 μV, p<0.05 (Figure 2.41B). At 1 month post-
injury, the amax recovered, but the bmax was significantly reduced at several light 
Figure 2.40. Visual acuity declines after blast in both Bl/6 (A) 
and D2 (B). The average cycles/degree ± SEM are plotted over 
time. **p<0.01 
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intensities. At -1 log cd*s/m2 the bmax was decreased 42% from 335.2 ± 18.2 μV to 193.7 
± 31.4 μV, p<0.01 (Figure 2.41D). At 1 log cd*s/m2 the bmax was decreased 33% from 
451.3 ± 25.9 μV at baseline to 301.2 ± 35.7 μV, p<0.01 (Figure 2.41D). The oscillatory 
potentials did not change after blast in the D2 (Figure 2.41E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2.41. Blast causes ERG deficits in the D2, but not the Bl/6. 
Graphs of the average ± SEM of amax (A-B), bmax (C-D) and oscillatory 
potentials (E-F) for Bl/6 and D2 mice, respectively, at baseline, 1 
week and 1 month post-injury. *p<0.05 
 82 
Ocular trauma did not damage the olfactory epithelium or optic nerves 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
The olfactory epithelium was examined in 1 week post-injury Bl/6 mice for evidence of 
blast injury to the tissue between the eyes (Figure 2.42A-D). We observed no 
differences between sham and blast animals with either nitrotyrosine immunolabeling 
(Figure 2.42A, C) or TUNEL (Figure 2.42B, D). 
 
 
 
Figure 2.42. Blast has no effect on the Bl/6 olfactory epithelium. 
Representative epifluorescence micrographs of sham (A-B) and 1 week 
post-injury (C-D) olfactory epithelium immunolabeled for nitrotyrosine 
(A,C, green) and TUNEL (B,D, red). The scale bar in (A) is 50µm and 
applies to all images. 
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Since degenerative axons in the blast-exposed optic nerve were most evident at 
1 month post-injury, we examined contralateral optic nerves from both strains at 1 
month post-injury (Figure 2.43A-D). There were no differences between contralateral 
optic nerves (Figure 2.43C-D) and control optic nerves (Figure 2.43A-B). 
 
 
 
 
Figure 2.43. The optic nerve is unaffected by trauma. Representative 
micrographs of control (A-B) and 1 month post-injury (C-D) optic nerve 
cross-sections. The scale bar in (A) is 20µm and applies to all 
micrographs. 
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Discussion 
Mild, progressive trauma in the Bl/6 mouse  
Ocular blast trauma in the Bl/6 mouse induces a delayed injury response similar 
to what has also been described in models of TBI (Johnson et al., 2013) and in 
Veterans with blast-induced mild TBI (Cockerham et al., 2009, 2011; Weichel et al., 
2009). The injury phenotype is mild when compared to the D2 and Balb/cJ mice 
(Bricker-Anthony et al., 2014a, 2016b) and is similar to closed-globe injuries reported in 
blast-exposed veterans (Cockerham et al., 2011). However, certain findings such as 
delayed cell death and optic nerve degeneration, as well increased oxidative stress and 
inflammation over time, are suggestive of subtle, ongoing degeneration after blast 
exposure. 
Cell death did not occur in the Bl/6 eye until 1 month post-injury and only covered 
3% of the retina, whereas substantial cell death occurred in the D2 and Balb/cJ retinas 
within days of the injury. Since most cell death occurred in the outer retina, we expected 
to see deficits in the ERG. However, the small, focal pockets of cell death we observed 
are likely insufficient to interfere with visual function. Normal ERG amplitudes after blast 
is also consistent with findings in the shock tube model (Mohan et al., 2013).  
RIP3, a marker of necroptosis, was the only cell death marker substantially 
increased in the outer retina after blast. RIP3 directly interacts with several 
mitochondrial enzymes and pushes metabolism into overdrive when overexpressed, 
resulting in excess production of reactive oxygen species and necrosis (Bergsbaken et 
al., 2009). Both TNF-α and RIP3 have also been reported to increase activation of 
microglia (Trichonas et al., 2010). Detection of RIP3 in the ONL at 1 month after blast 
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correlated with detection of reactive microglia and increased nitrotyrosine 
immunolabeling in the ONL. These findings suggest that RIP3 may also contribute to 
both microglial activation and oxidative stress in the outer retina, which may result in 
ongoing retinal degeneration after blast.  
TUNEL-positive cells were also detected in the INL in a subset of retinas. In other 
blast models, the most consistent and robust molecular changes were detected in the 
inner retina and involved nitrosative stress (Mohan et al., 2013; Zou et al., 2013). 
Exposure to TNT at the same the same blast pressure used in our study elicited 
increased iNOS labeling in the inner retina (Zou et al., 2013). Therefore, it is possible 
that increased peroxynitrite immunolabeling and increased RIP1, RIP3 and caspase-1 
immunolabeling in the INL are linked, as oxidative stress both initiates and results from 
pyroptosis and necroptosis (Bergsbaken et al., 2009; Fink et al., 1999; Jin and Flavell, 
2010). 
Caspase-1 immunolabeling in the starburst amacrine cells has interesting 
implications for both functional and pathological outcomes following blast injury. 
Starburst amacrine cells are critical for signaling directional selectivity onto downstream 
RGCs and are, therefore, necessary for the OKN response that is used to measure 
visual acuity (Taylor and Smith, 2012). Damage to the starburst amacrine cells could 
explain the decrease in visual acuity after blast in our model. Caspase-1 
immunolabeling was also present in inner retinal cells negative for ChAT. AII amacrine 
cells, which belong to a major amacrine cell population (glycinergic amacrine cells) in 
the retina (Haverkamp and Wässle, 2000), are involved in the transmission of rod 
photoreceptor signals to the retinal ganglion cells (Helga Kolb, 2016).  The spread of 
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caspase-1 labeling from small retinal regions at 3 days post-blast to amacrine cells 
throughout the entire retina at 1 month post-blast suggests spread of a molecular signal 
inducing increased levels of caspase-1 in neighboring cells. AII amacrine cells are 
connected to each other by connexin-mediated gap junctions (Hampson et al., 1992), 
through which small signaling molecules can travel to enact neuroprotection or 
neurodegeneration (Danesh-Meyer et al., 2012; Massey et al., 2003; Paschon et al., 
2012; Striedinger et al., 2005; Yoon et al., 2010).  
 Despite the lack of RGC death in our model at 28 days post-blast, our results 
suggest that the RGCs may die at later time points, as reported in other blast models 
(Koliatsos et al., 2011; Mohan et al., 2013). First, we begin to detect axon degeneration 
at 1 month post-blast, which may precede RGC death as it does in traumatic optic 
neuropathy (Warner and Eggenberger, 2010). Second, labeling for nitrotyrosine and 
markers of pyroptosis and necroptosis in the GCL are increased at 1 month post-blast, 
which is consistent with other studies showing the first evidence of RGC death at 4 
months post-blast (Mohan et al., 2013). 
In summary, markers of oxidative stress and inflammation increase over time 
after blast and are primarily localized to the inner retina, suggesting that inner retinal 
changes may drive visual deficits and that further cell death may be expected at later 
time points after blast. This study provides molecular insight into the effects of ocular 
trauma on the neural retina that may underlie the delayed vision loss that occurs in 
blast-exposed patients despite a normal ophthalmological exam.  
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Severe trauma in the D2 mouse 
 A large influx of immune cells into the eye occurred after blast in the D2, but not 
in the Bl/6 or Balb/cJ, which have a fully intact ACAID. The immune response after 
trauma elicited formation of epiretinal membranes, increased nitrosative stress, greater 
cell death, and more severe vision loss than was detected in the Bl/6 or Balb/cJ mice 
(Bricker-Anthony et al., 2014b, 2016b). The RPE damage in the D2 at 3 days post-injury 
was severe when compared to the Bl/6 and Balb/cJ at 1 week post-blast. Remarkably, 
despite the early and dramatic vacuolization and significant amount of subretinal debris 
present within days after blast, the RPE and subretinal space appeared near normal at 
1 month after injury, like the Bl/6. These findings show that the RPE cells are very 
resilient and are adept at phagocytosing and removing subretinal debris.  
The differences in response to blast between the D2 mouse and the Bl/6 and 
Balb/cJ mouse strains are consistent with comparisons between open globe and closed 
globe trauma patients (Scott, 2011). Blast injury in the D2 mouse resulted in rapid, 
severe vision loss that failed to recover by 1 month (Bricker-Anthony et al., 2014a). In 
contrast, blast injury in the Bl/6 mouse only induced a mild deficit in visual acuity that 
recovered by 1 month (Bricker-Anthony et al., 2014b). In blast-exposed human patients, 
open globe injuries initially caused severe visual acuity deficits, ranging from 5/200 to 
no light perception (Erdurman et al., 2011). After 6 months, 45% of the patients had no 
light perception, while the remaining 55% of patients had visual acuity ranging from 
>20/40 to light perception (Erdurman et al., 2011). In contrast, human patients with 
blast-induced closed injuries had better initial visual acuity (ranging from >20/40 to light 
perception) and 66% of the patients had visual acuity >20/40 after 6 months (Erdurman 
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et al., 2011). Blast injury in the D2 mouse also induced peripheral immune cell 
infiltration, which was absent in both the Bl/6 and Balb/cJ mice after blast. Peripheral 
immune cell infiltration also occurs in endophthalmitis, an inflammatory intraocular 
condition (Egan et al., 2016) that can affect human patients with open globe injuries, but 
typically does not affect patients with closed globe injuries (Cebulla and Flynn, 2009).  
In endophthalmitis, ocular immune privilege is lost and peripheral immune cells invade 
the eye and secrete damaging inflammatory cytokines  that can lead to retinal cell death 
and profound vision loss (Callegan et al., 2002). 
 As in the post-blast Bl/6 retina, the cell death pathway appeared to be non-
apoptotic in the D2 retina (Bricker-Anthony et al., 2014b). In both mice, we detected 
increases in markers for necroptosis (RIP1 and RIP3) after blast, suggesting that 
necroptosis is the main cell death pathway activated after blast. The peak of cell death 
was earlier in the D2 – 3 days as compared to 1 month in the Bl/6 or 1 week in the 
Balb/cJ (Bricker-Anthony et al., 2014b, 2016b). Additionally, we observed more TUNEL-
positive nuclei in the D2 retina than in the Bl/6 or Balb/cJ retinas. Like the Bl/6, optic 
nerve damage occurred at 1 month post-injury, but it was more severe than in the Bl/6 
or Balb/cJ at the same time point.  
There were also differences between our blast model in the D2 and other models 
of blast injury. Unlike the whole body/head blast models (Goldstein et al., 2012; Mohan 
et al., 2013), photoreceptor cell death was present in this model and in a TNT blast 
study (Zou et al., 2013). The discrepancies may be due to the physics of head 
movement in their model as compared to our model and the TNT model (Zou et al., 
2013). Similar to Mohan et al., we detected RGC death and degeneration in the optic 
 89 
nerve (Mohan et al., 2013). They reported axon degeneration and RGC loss at 10 
months post-blast in the Bl/6 mouse while we showed that it may begin as early as 3 
days in the D2 and Balb/cJ mice or 1 month post-blast in the Bl/6 mice.  
The pathological changes after blast in the D2 mouse, such as Mϋller glia 
reactivity, nitrosative stress and immune infiltrate, were consistent with findings in the 
high-level blast exposure group at 2 weeks post-injury in the TNT model (Zou et al., 
2013). The Bl/6 and Balb/cJ mice exhibited a milder phenotype like the low-level blast 
group in the TNT study. We suspect these differences are due to the presence of 
immune infiltrate in the D2 mouse and their high-level blast animals, which was absent 
from our Bl/6 and Balb/cJ mice and their low-level blast animals.  
Compared to Bl/6, the D2 mice had significant visual function deficits post-injury 
as measured by the ERG. Acutely, the visual acuity and ERG amplitude deficits appear 
to be driven by damage to the outer retina. Photoreceptor and RPE damage likely drove 
the early ERG deficits, as the a wave was more affected than the b wave. These deficits 
in visual function correlated with the presence of retinal detachments and extensive 
vacuolization in the RPE, indicative of oxidative stress (Fujihara et al., 2008), in the first 
week after injury. The RPE damage may have temporarily impaired recycling of 11-cis-
retinal (Schraermeyer and Heimann, 1999), which could have driven the transient 
reduction in the ERG a wave.  The recovery of the OKN at 1 week post-blast may reflect 
resolution of the RPE damage in combination with an improvement in the OKN 
response as a result of repeat testing (Prusky et al., 2008).  A similar decrease and 
subsequent recovery of visual function occurred in our model with the Bl/6 mouse and in 
Mohan and colleagues’ blast model (Bricker-Anthony et al., 2014b; Mohan et al., 2013). 
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Temporary deficits in visual acuity are also observed in patients following blast injury 
(Alam et al., 2012; Phillips et al., 2013).  
At 1 month post-blast, the ERG amplitudes were affected in a different manner. 
The ERG b wave and visual acuity continued to decrease at 1 month post-blast as the a 
wave improved. These findings suggest ongoing dysfunction in the inner retina after 
blast. These results are supported by the detection of a second wave of TUNEL-positive 
cells and significant optic nerve degeneration at 1 month post-blast. The detection of 
TUNEL positive cells prior to any degenerating axons in the optic nerve suggests that 
the axon degeneration is secondary to RGC death.  
In summary, this study demonstrates that an overpressure air-wave directed at 
the eyes of adult DBA/2J mice could be potentially used as a model for open-globe 
ocular trauma. This model is attractive because the globe remains intact, avoiding 
complications from potential bacterial infections. Treatment options for open globe 
trauma patients are very limited and none have shown a high degree of success. We 
expect that this model will be useful as a platform for identifying the mechanisms 
underlying ongoing vision loss and testing potential therapeutics for the treatment of 
open-globe ocular trauma. 
 
Moderate trauma in the Balb/c mouse 
Optic nerve degeneration occurred rapidly in the Balb/c after blast, compared to 
the Bl/6 and D2. We did not detect any degenerating axon profiles in the Bl/6 and D2 
optic nerves until 1 month post-injury (Bricker-Anthony et al., 2014b; a). In contrast, the 
Balb/c optic nerves contained degenerating axons as early as 1 week post-injury. 
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Traumatic optic neuropathy, which can occur after blast or blunt trauma in humans 
(Phillips et al., 2013; Thach et al., 2008; Weichel and Colyer, 2008), is thought to be 
induced by two different injury mechanisms: primary (shearing of the axons and 
ischemia) and secondary (initial damage and death of the retinal ganglion cells) 
(Samardzic et al., 2012). We detected very little cell death in the GCL after blast, so it is 
possible that the retinal ganglion cells remained alive prior to axon degeneration, 
supporting a role for primary optic nerve injury. The Balb/cJ is more susceptible to optic 
nerve crush than the Bl/6 and the D2 (Li et al., 2007), so it is possible that genetic 
differences are driving the early onset of axonal degeneration in the Balb/cJ post-blast. 
Further, this model may be more representative of clinical traumatic optic neuropathy 
than the optic nerve crush or axotomy models.  
Vacuolization of the RPE, a symptom of oxidative stress (Fujihara et al., 2008), 
occurred in all three mouse strains post-injury. RPE damage was also reported in 36% 
of blast-exposed soldiers (Phillips et al., 2013). In contrast to the Bl/6 and D2 mice, RPE 
vacuolization did not resolve in the Balb/cJ (Bricker-Anthony et al., 2014b; a). The RPE 
is an important component of the blood-retina barrier (Peyman and Bok, 1972) and is 
essential for photoreceptor health and function (Strauss, 2005). Enduring oxidative 
damage to the RPE could potentially cause loss of ocular immune privilege and ensuing 
inflammation. Oxidative stress and blood-brain-barrier permeability also occur in models 
in blast-induced traumatic brain injury, suggesting a similar mechanism in the eye and 
brain (Abdul-Muneer et al., 2013; Readnower et al., 2010).  
 Delayed neuronal cell death after blast exposure is a common finding in models 
of blast-induced traumatic brain injury (Koliatsos et al., 2011; Mohan et al., 2013). The 
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accelerated cell death in the D2 and Balb/cJ as compared to the Bl/6 in our model might 
be due to the greater inflammatory response exhibited by these two strains including 
Müller cell reactivity and peripheral immune cell infiltration (Bricker-Anthony et al., 
2014b; a). Reactive Müller cells can cause retinal edema, secrete inflammatory 
cytokines and promote macrophage infiltration (Tong and Verkman, AS, 2004; 
Nakazawa et al., 2006). We also detected increases in some pro-inflammatory 
cytokines and chemokines as early as a few days post-trauma, including IP-10 and KC. 
IL-1 can induce expression of IP-10, KC, and MCP-1 from neurons (Tsakiri et al., 
2008). While we did not detect a statistically significant increase in IL-1, levels at both 
time points trended up and might explain the increases in these chemokines. These 
chemokines are also increased in other models of CNS injury and can act on both glia 
and neurons to mediate the recruitment and infiltration of peripheral immune cells into 
the CNS (Barbero et al., 2002; Cho and Miller, 2002). These findings suggest that there 
may be an increase in microglia in the retina after ocular blast trauma. While acute 
neuroinflammation is protective, chronic neuroinflammation can contribute to 
neurodegeneration.  
 The increase in IL-10 in the combined 3 day and 1 week post-trauma retinas is 
suggestive of an endogenous protective response. IL-10 is an anti-inflammatory 
cytokine that inhibits activation of macrophages, microglia and astrocytes and blocks 
production of pro-inflammatory cytokines and iNOS, resulting in lower levels of 
peroxynitrite (Bogdan et al., 1992; Cunha et al., 1992; de Waal Malefyt et al., 1991; 
Ledeboer et al., 2000; Lodge and Sriram, 1996; Pousset et al., 1999; Sawada et al., 
1999). Gene delivery of IL-10 decreases nitrotyrosine immunolabeling and preserves 
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ganglion cells in an optic nerve axotomy model (Koeberle et al., 2004). This strategy 
may also be effective in the treatment of ocular blast trauma. 
In conclusion, the Balb/cJ mouse model of ocular blast trauma provides a good 
platform for testing cell-based therapies. These therapies are much needed, as there 
are currently no treatment options for eye trauma patients. 
 
Mild blunt trauma in the contralateral eye after blast 
 The mechanism of injury to the contralateral eye in this model system appears to 
be mild blunt trauma based on three main findings. First, absence of cell death and 
nitrosative stress in the olfactory epithelium argues against blast wave propagation 
through the head, as this would likely damage the delicate tissue. Second, the lack of 
damage to the contralateral optic nerve also supports this hypothesis since blast waves 
contain shearing forces that are particularly damaging to long structures such as axons 
(Garman et al., 2011). Third, the timing of cell death was the same in the contralateral 
eyes of both mouse strains, but was different from the respective blast-exposed eyes 
(Bricker-Anthony et al., 2014b; a). One would expect similar timing of cell death if both 
eyes were injured by the same injury mechanism (i.e. blast). 
Our injury system produced pathology similar to that observed in animal models 
of blunt ocular trauma and in patients with commotio retinae (Blight and Hart, 1977; 
Sipperley et al., 1978; Bunt-Milam et al., 1986; Blanch et al., 2012). Commotio retinae is 
characterized by focal damage to the RPE and photoreceptors that spontaneously 
resolves in the majority of patients (Blight and Hart, 1977; Sipperley et al., 1978; Bunt-
Milam et al., 1986; Blanch et al., 2012). Similar to our findings, focal pyknotic 
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photoreceptor nuclei were also detected soon after ocular trauma in both primate and 
rodent models (Sipperley et al., 1978; Blanch et al., 2012). Finally, porcine and feline 
models of blunt trauma also exhibit RPE vacuolization and focal photoreceptor damage 
within the first week post-injury, which resolved at one month post-injury (Blight and 
Hart, 1977; Bunt-Milam et al., 1986). Also consistent with trauma, we detected retinal 
detachments in both strains. Surprisingly, in the D2 mouse, we detected retinal 
detachments at 2 weeks, but not 1 week post-trauma. One possible explanation is that 
we missed the retinal detachments at 1 week due to how the mouse was positioned in 
the OCT system, or which retinal regions were imaged. However, since we rotate the 
mouse and probe to visualize as much of the retina as possible, we find this explanation 
unlikely. Another possible explanation is that the retinal detachments developed over 
time. A recent study detected delayed retinal detachments in trauma patients (Xia et al., 
2015). 
 In contrast with these other models, we also observed TUNEL-positive nuclei and 
labeling with necroptotic cell death markers in the inner retina. In a rat model of ocular 
trauma, the authors stated that the inner retina was mostly spared and did not report 
TUNEL quantification for the inner retina (Blanch et al., 2012). The pattern of their ERG 
deficits is also incongruous with our findings. They reported a deficit in both the amax and 
bmax with equal timing and extent, while we saw an initial decrease in the amax, followed 
by a recovery of the amax and subsequent decline in the bmax in the D2 mice. These 
findings suggest that the ERG deficits observed in their model were due to 
photoreceptor cell loss that resulted in loss of downstream signaling to the inner retina. 
In contrast, our ERG results show an early, transient deficit in the photoreceptor cells 
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followed by inner retina dysfunction. These incongruent results are likely due to 
differences between the injury models and the rodent species (Bl/6 and D2 mice were 
used in our study and Lister hooded rates were used in their study). 
The visual acuity in the Bl/6 eyes were consistent with our previous findings in 
the blast-exposed eyes (Bricker-Anthony et al., 2014b). While OKN scores normally 
improve with repeat testing in mice, there was no improvement in the Bl/6 eyes after 
injury (Prusky et al., 2008). The ongoing cell death from 1 week to 1 month post-injury in 
the Bl/6 eyes may contribute to the decreased OKN response. There were also no 
changes in the ERG post-injury, like the blast-exposed eye (Bricker-Anthony et al., 
2014b). The lack of lens displacement suggests that the discrepancy is not due to 
altered optics. It is feasible that the blunt trauma injured other, non-retinal, neuronal 
pathways necessary for the OKN response (Chevallier et al., 2013). In contrast, the 
OKN scores and ERG results were very similar between D2 blast-exposed and 
contralateral eyes (Bricker-Anthony et al., 2014a).  
In conclusion, our model, which directs a blast of air towards one eye, causes injury to 
the contralateral eye likely because of pushing the head onto the cushioning within the 
housing chamber. The lack of ERG deficits, optic nerve damage, anterior pathologies 
and the spontaneous recovery of the outer retina damage suggest that this is a model of 
mild blunt trauma. The injury profile in the contralateral retina of the D2 mouse is more 
severe than that of the Bl/6 mouse, which is consistent with the greater 
neuroinflammation in the D2. Thus, our model system can be used to explore 
mechanisms and functional outcomes of both blast and blunt ocular trauma (e.g. 
damage from both the primary and secondary effects of blast) separately. Future 
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studies may investigate the effects of combining both blast and blunt injuries in the 
same eye, as this is relevant for blast-injured U.S. military veterans who often 
experience a combination of both primary and secondary blast trauma. 
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CHAPTER 3 
 
DELAYED TREATMENT WITH ERYTHROPOIETIN REDUCES RETINAL CELL 
DEATH AND NITROSATIVE STRESS AFTER OCULAR BLAST TRAUMA3 
 
Introduction 
 EPO is an endogenous cytokine best known for its role in stimulating 
hematopoiesis and is clinically approved for the treatment of anemia (Eschbach et al., 
1987). Many laboratories became interested in EPO when it was shown to exert 
neuroprotection in vitro (Morishita et al., 1996). Previous studies demonstrated that 
EPO is neuroprotective and improves cognitive outcomes following traumatic brain 
injury (Lu et al., 2005; Yatsiv et al., 2005). As such, the efficacy of EPO treatment for 
traumatic brain injury is currently being evaluated in several clinical trials 
(www.clinicaltrials.gov).  EPO is composed of four α-helices joined together by three 
crossover loops (Cheetham et al., 1998). There are two binding sites for the EPO 
receptor homodimer (EPOR) on the surface of EPO, consisting of a high affinity and a 
low affinity binding site (Cheetham et al., 1998). EPO mRNA is highly expressed in the 
kidney and liver, but is also present in neuronal tissue (Tan et al., 1992). EPO is a 
potentially promising treatment for traumatic brain injury and other insults, but systemic 
                                            
3 Portions of this chapter were published as Bricker-Anthony C (2014). Ocular blast 
trauma: models, mechanisms and a potential therapeutic strategy. VRN 6; Bricker-
Anthony C, D’Surney L, Lunn B, Hines-Beard J, Jo M, Bernardo-Colon A and Rex TS 
(2016). Erythropoietin either prevents or exacerbates retinal damage from eye trauma 
depending on treatment timing. Optom Vis Sci 93. 
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treatment with EPO can lead to the development of polycythemia, a potentially life-
threatening condition. 
 To reduce the risk of polycythemia when EPO is used for neuroprotection, Leist 
and colleagues generated several modified forms of EPO (Leist et al., 2004). 
Carbamylation of EPO (CEPO) resulted in a dearth of binding to the EPOR homodimer, 
yet it remained neuroprotective both in vitro and in vivo (Leist et al., 2004). Two 
separate mutations in the low affinity binding site, S100E and R103E, were also 
effective at preventing binding to the EPOR homodimer while maintaining 
neuroprotection (Leist et al., 2004). Our lab also developed a mutant form of EPO, EPO-
R76E, which protected RGCs in D2 glaucomatous mice and displayed attenuated 
erythropoiesis, indicative of poor binding to EPOR homodimer (Sullivan et al., 2011). 
Brines and colleagues demonstrated that EPO and CEPO bind an EPO R and ILβ-
subunit R heterodimer, which provides tissue protection without stimulation of 
hematopoiesis (Brines et al., 2004).  
 Though EPO is neuroprotective in multiple models of neuronal stress and 
disease, its precise mechanisms are still unclear. The addition of neurprotective EPO 
mutants with attenuated or abolished hematopoietic activity by Leist and colleagues and 
our lab also complicates the question of EPO’s protective mechanisms (Leist et al., 
2004; Sullivan et al., 2011). Binding of EPO to its native receptor homodimer initiates 
erythropoiesis via the Jak/Stat signaling cascade and appears to promote erythrocyte 
survival via GATA-1-mediated upregulation of anti-apoptotic Bcl-XL (Gregory et al., 
1999; Parganas et al., 1998). However, EPO neuroprotective pathways appears to vary 
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even among different neuronal populations and may have a more widespread impact 
than just preventing cell death at the level of the individual neuron. 
In an in vitro model of neuronal hypoxia, administration of EPO induced 
increased phosphorylation of Stat5, Akt, ERK1 and ERK2 in hippocampal neurons 
(Sirén et al., 2001b). Addition of inhibitors of the MAPK and PI3K pathways in 
conjunction with EPO treatment prevented phosphorylation of ERK1, ERK2 and Akt and 
abolished EPO neuroprotection (Sirén et al., 2001b). Activation of the MAPK pathway 
provides protection via inhibition of pro-apoptotic BAD and phosphorylation of CREB, 
which transcribes pro-survival genes (Bonni et al., 1999). Phosphorylation of Akt within 
the P13K pathway also prevents activation of BAD and leads to downstream activation 
of Nf-κB, which promotes transcription of pro-survival genes (Brunet et al., 2001). 
 Another in vitro model of excitotoxicity and neuroinflammation in cerebrocortical 
neurons showed that Jak2-mediated activation of Nf-κB was necessary for EPO 
neuroprotection (Digicaylioglu and Lipton, 2001). Following phosphorylation of Jak2 by 
the EPOR, Jak2 phosphorylated IκBα, a potent suppressor of Nf-κB (Digicaylioglu and 
Lipton, 2001). Together, these findings support a common pathway for EPO 
neuroprotection, as Jak2 contributes to both MAPK and PI3K signaling cascades (De 
Vos et al., 2000; Wolf et al., 2013).  
 However, findings from Weishaupt and colleagues challenged the notion that 
MAPK signaling was involved in EPO neuroprotection within RGCs (Weishaupt et al., 
2004). To test the efficacy of EPO neuroprotection in RGCs, Weishaupt and colleagues 
used both an in vitro (trophic factor deprivation in RGC cultures) and in vivo (optic nerve 
transection, an acute model of glaucoma) approach. The authors documented EPOR 
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expression, RGC survival, phosphorylated Akt expression and the effects of a PI3K 
inhibitor, Wortmannin.  
 The authors detected EPOR on the RGCs of both control and optic nerve 
transected rats. The authors claimed that the EPOR expression was much weaker in 
other cell types of the retina. However, this finding disagrees with data from Xie and 
others, who reported EPOR expression throughout the layers of the retina without 
strong localization within the RGCs in normal Sprague-Dawley rats, the same rat breed 
used by Weishaupt and colleagues (Xie et al., 2007). Grimm and colleagues also 
reported a different EPOR expression pattern within the normal mouse retina (strong 
staining within photoreceptor inner segments and the outer plexiform layer, weak 
labeling within the inner retina), but these results could be due to a species difference 
(Grimm et al., 2002). A current challenge in the field is the lack of specificity of EPOR 
antibodies (Elliott et al., 2006). 
EPOR expression also failed to change significantly in response to optic nerve 
transection or EPO treatment. The lack of change in EPOR expression is not surprising, 
given that HIF-1α induces increases in EPO and increases in both EPO and EPOR 
have been reported in the hypoxic brain (Semenza, 2001; Sirén et al., 2001a). In 
contrast, optic nerve transection is not a hypoxic injury and is not likely to induce 
increased expression of HIF-1α.  
Surprisingly, EPO treatment elicited phosphorylation of Akt, but not of ERK1/2 in 
optic nerve transected retinas. Both the MAPK and PI3K pathways are active and 
involved in EPO neuroprotection in cerebral ischemia and intracerebral hemorrhage 
(Kilic et al., 2005; Lee et al., 2006b; Sirén et al., 2001b). A possible explanation for the 
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lack of ERK1/2 phosphorylation in this study is that the neuroprotective cascade 
initiated by EPO differs in RGCs compared to cerebral neurons. However, a recent 
study demonstrated that inhibition of MAPK, PI3K, or Stat5 in cultured rat RGCs 
challenged with trophic factor withdrawal, TNF-α, or NMDA resulted in a significant loss 
of EPO neuroprotection (Chang et al., 2013). However, the reduction in EPO 
neuroprotection varied among RGC types and with the type of insult. These findings 
suggest that different cytotoxic stimuli and cell types may result in alterations in EPO’s 
neuroprotective signaling cascades, which needs to be explored further in future 
experiments.  
In addition to preventing apoptosis at the level of the individual neuron, EPO has 
also been shown to affect both astrocytes in the brain and Müller glia in the retina 
(Gunnarson et al., 2009; Hu et al., 2010). EPO treatment significantly reduced water 
permeability within AQP4 positive astrocytes and decreased abnormal calcium 
oscillations following induction of edema (Gunnarson et al., 2009). In a model of diabetic 
retinopathy, EPO treatment also reduced reactive gliosis and promoted expression of 
neurotrophins in Müller glia (Hu et al., 2010). EPO may also modulate immune 
responses in neuronal disease and injury, as recently discussed by Brines and Cerami 
(Brines and Cerami, 2012).  
EPO may also provide neuroprotection through reduction of oxidative stress. 
Previous studies demonstrated that EPO treatment reduces oxidative stress in both 
diseased and injured states (Wang et al., 2010; Yazihan et al., 2008). EPO may reduce 
oxidative stress directly by scavenging reactive oxygen species or indirectly by 
activating the antioxidant response element and increasing antioxidant enzyme levels 
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(Bond and Rex, 2014). If oxidative stress contributes to neurodegeneration after blast 
exposure, then EPO may block its effects.  
Given its ability to protect neurons in a variety of cytotoxic conditions, EPO is a 
promising treatment for ocular blast trauma. However, many important questions about 
EPO neuroprotection remain. Several studies reported dose-response differences with 
EPO treatment (Chang et al., 2013; Digicaylioglu and Lipton, 2001; Sirén et al., 2001b; 
Weishaupt et al., 2004). Determining an optimal dosage for EPO neuroprotection will be 
crucial for moving forward into patient populations.  
Two final questions include local versus systemic administration and the timing of 
treatment. Weishaupt and colleagues obtained neuroprotection with an intravitreal 
injection of EPO protein (Weishaupt et al., 2004). However, an intravitreal injection may 
not be suitable for the injured eye. If EPO mutants are utilized, then systemic 
administration is an option, given that hematopoiesis is attenuated with EPO mutants 
and EPO can cross the blood-retina barrier. For acute treatment of ocular blast trauma, 
systemic administration of wild-type EPO is also acceptable, as it would not greatly 
impact hematocrit as it would in the context of chronic treatment. Another possible 
treatment method is gene therapy. Rex and colleagues showed significant therapeutic 
benefit with intramuscular injection of a viral vector (recombinant adeno-associated 
virus; rAAV)  driving expression of EPO protein in a rat model of retinal light damage, a 
mouse model of retinal degeneration and mouse model of glaucoma (Rex et al., 2004; 
Sullivan et al., 2011b). A gene therapy approach may be beneficial for ocular blast 
trauma, as it allows for sustained expression of EPO over time, which could combat any 
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long-term neurodegeneration, which was observed Mohan and colleagues’ model of 
ocular blast trauma (Mohan et al., 2013). 
 To evaluate the efficacy of EPO for the treatment of ocular blast trauma, we used 
D2 and Balb/cJ mice, which exhibited severe and moderate damage, respectively, after 
blast exposure. We used EPO protein to determine if short-term treatment with EPO 
soon after blast would be sufficient to protect the D2 retina. We chose a 3 day time point 
to coincide with the peak of cell death after blast in the D2 mouse and a 7 day time-
point to allow sufficient time for changes in gene expression to overcome the elevation 
in erythropoiesis. Since EPO has a short half-life, frequent re-injection was needed so 
the shortest duration was optimal to limit the number of re-injections necessary. To 
provide long-term, sustained delivery, we used an rAAV in the Balb/cJ mice, which 
exhibited the most retinal damage with 7 days of injury and the most optic nerve 
damage within 1 month of injury. To avoid the large increase in erythropoiesis that is 
caused by sustained production of EPO, we instead delivered EpoR76E, a form of EPO 
with attenuated erythropoietic activity and well-characterized neuroprotective properties 
in multiple models of retinal disease and injury (Sullivan et al., 2011b; a, 2012). We 
injected mice with rAAV.EpoR76E either before or one day after blast to compare the 
efficacy of treatment (elevated EPO-R76E) at blast to treatment initiated at 3 weeks 
after blast, long after the early rise in oxidative stress.  
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Materials and Methods 
Animals 
Three-month old DBA/2J or Balb/cJ mice (The Jackson Laboratory, Bar Harbor, 
ME) were maintained on a 12h light/dark cycle and provided access to food and water 
ad libitum. All experimental procedures were approved by the Institutional Animal Care 
and Use Committee of Vanderbilt University, according to AALAC guidelines. Age-
matched controls were used throughout the study. For histological analyses mice were 
perfused with 4% paraformaldehyde (PFA; Electron Microscopy Sciences, Hatfield, PA) 
and phosphate buffered saline (PBS), enucleated, and the eyes were stored in 4% PFA.  
For RNA collection mice were euthanized, corneas were bisected, and forceps were 
used to separate the retina from the posterior globe. The vitreous was removed from the 
isolated retina, which was then frozen on dry ice and stored at -80oC. 
 
Ocular Blast Injury 
Isofluorane anesthetized mice were secured and padded within a housing 
chamber that was placed within a larger tube, which shielded the body and head of the 
mouse from blast. The left eye of the mouse was positioned against a hole in the tube 
and was aligned with the barrel of the blast device. An overpressure air-wave with a 
peak pressure of 26psi was produced by a modified paintball marker (Empire Paintball, 
Sewell, NJ).  
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Erythropoietin Therapy – DBA/2J 
 Mice were given three intraperitoneal injections of 5,000U/kg EPO (Procrit, Ortho 
Biotech, Bridgewater, NJ) at 24h intervals. Control mice received Ringer’s buffer. There 
were four treatment groups based on the timing of EPO delivery after blast and timing of 
tissue collection: 1) EPO delivered at 0, 24, and 48h post-blast, tissue collected at 7-
days post-blast; 2) EPO delivered at 6, 30, and 54h post-blast, tissue collected 7-days 
post-blast; 3) EPO delivered at 24, 48, and 72h post-blast, tissue collected at 7-days 
post-blast; and 4) EPO delivered at 24, 48, and 72h post-blast, tissue collected at 3-
days post-blast.  
 
Gene Therapy – Balb/cJ 
 Mice were given a single intramuscular injection of recombinant adeno-
associated virus (rAAV) carrying either enhanced green fluorescent protein 
(rAAV2/8.CMV.eGFP) or a mutated form of EPO with attenuated erythropoietic activity 
(rAAV2/8.CMV.EpoR76E) at 1x109gc into the quadriceps. Vectors were produced, 
purified, and titred at the University of Pennsylvania Vector Core (Philadelphia, PA). In 
the pre-blast group mice were injected 1-month prior to blast and collected at 1-month 
post-blast. In the post-blast group mice were injected 1-day post-blast and collected at 
1-month post-blast. The rAAV2/8 serotype reaches peak gene expression levels three 
weeks after intramuscular injection (Louboutin et al., 2005). The collection time point 
was chosen based on the amount of time necessary for gene expression from rAAV and 
our previous data showing persistence of cell death at this time point. This paradigm 
allowed us to test if delayed delivery of EPO-R76E was therapeutic. 
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Immunohistochemistry  
Eyes were embedded in Tissue Freezing Medium (Electron Microscopy 
Sciences) and 10m thick sections were collected in-round on 12 slides such that each 
slide contained a representation of all areas of the eye/retina. Slides were rinsed with 
phosphate buffered saline (PBS) and incubated at room temperature in normal donkey 
serum at 1:20 in 0.1 M phosphate buffer with 0.5% bovine serum albumin and 0.1% 
Triton X 100 (PBT) for 2 hours. The slides were incubated overnight at 4°C in anti-
nitrotyrosine (1:500, Millipore, Billerica, MA), anti-glial fibrillary acidic protein (GFAP, 
1:400, DAKO, Carpinteria, CA), or anti-H ferritin (1:100, Abcam, Cambridge, MA) in 
PBT, rinsed with PBS and incubated with a secondary antibody (Life Technologies, 
Grand Island, NY) for 2 hours at room temperature. Slides were rinsed with PBS and 
mounted in Vectashield Mounting medium with 4’,6-diamidino-2-phenylindole (DAPI; 
Vector Laboratories, Burlingame, CA) for imaging on a Nikon Eclipse epifluorescence 
microscope (Nikon, Melville, NY).  
 
Quantification of Fluorescence Intensity 
 Non-overlapping, but adjacent images of all areas of all retinal sections were 
collected using the same gain and exposure settings. Fluorescence was quantified 
within a rectangle of a set width and a height equivalent to the height of the retinal layer 
of interest using Image J according to previously published methods (Weitlauf et al., 
2014).  
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Quantification of GFAP-positive processes 
 Non-overlapping, but adjacent images of all areas of all retinal sections, with the 
exception of the far periphery, were collected at low magnification and montages were 
assembled in Photoshop (Adobe). Using Image J, the total length of retina and the 
length of retina containing GFAP-positive processes were measured. The percent of 
retina containing GFAP-positive Müller cell processes was calculated by dividing the 
length of GFAP-positive retina by the total length of retina and multiplying by 100. 
 
Tdt dUTP Nick End Labeling (TUNEL) Quantification 
Retina sections were labeled with the TUNEL Apoptosis Detection Kit according 
to manufacturer’s protocol (Millipore, Billerica, MA) and mounted with Vectashield 
Mounting Medium with DAPI. Each slide contained 24 representative sections from all 
retinal regions. All sections were imaged and used in the quantification resulting in the 
analysis of an average of 57mm retina/group. The length of retina assessed in each 
group was not statistically different from the other groups with the following exceptions. 
The 3-day EPO and pre-blast therapy groups had less overall length of retina imaged 
and the 6hr EPO 7d post-blast group had slightly more retina imaged (p<0.05). A 
TUNEL-positive cluster was defined as an 85m2 area of retina containing five or more 
TUNEL-positive cells. Clusters within the inner retina (INL and GCL) and outer retina 
(ONL) were counted separately. The total number of TUNEL positive cells within each 
defined cluster was also quantified. Measurements were performed using NIS Elements 
Advanced Research software (Nikon, Melville, NY). The number of 3-day retinas 
analyzed was 3 for buffer-injected and 7 for EPO-injected. The number of 7-day post-
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blast retinas assessed per group was 17 for Buffer treated, 13 for 0h EPO, 9 for Group 
6h EPO, and 9 for 24h EPO. The number of Balb/c mouse retinas quantified was: 9 
rAAV.eGFP, 7 pre-blast rAAV.EpoR76E, and 9 post-blast rAAV.EpoR76E. 
 
Optic Nerve Histology 
Optic nerves were post-fixed in 4% paraformaldehyde and 1% glutaraldehyde 
and subsequently placed in 1% osmium tetroxide in 0.1 M cacodylate buffer, 
dehydrated in a graded ethanol series and embedded in Spurr’s resin (Electron 
Microscopy Sciences). Starting from the proximal end of the optic nerve, 1 μm-thick 
sections were collected using a Reichert-Jung Ultracute E microtome and stained with 
1% p-phenylenediamine in 50% methanol (Sigma-Aldrich). Sections were imaged on an 
Olympus Provis AX70 microscope using a 100x oil immersion objective lens. Axons 
were manually counted using ImageJ software by sampling 20% of the total nerve 
cross-sectional area using a fixed grid overlay to estimate axon density in the nerve 
(axons/mm2). Total number of surviving axons was estimated as the product of mean 
axon density and nerve cross-sectional area. Imaging and quantification were 
performed in a masked fashion. 
 
Oxidative Stress PCR Array 
The Qiagen oxidative stress RT2 profiler mouse oxidative stress kit was used 
according to manufacturers’ protocol. Five retinas were pooled for each plate. Data was 
normalized to the housekeeping gene, monogalactosyldiacylglycerol. 
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Statistical Analysis 
 All statistical analyses were calculated using Graphpad Prism software (San 
Diego, CA). The 7-day DBA/2J analyses were performed using ANOVA and a Tukey 
post-hoc test. All other data-sets were pair-wise comparisons and thus the Student’s t-
test was performed. The means ± SEM were calculated and presented for each data 
set. 
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Results 
Delayed, not acute, EPO therapy decreases retinal cell death after blast 
 No TUNEL-positive cells were detected in sham blast retinas (Figure 3.1A). In 
the buffer-injected DBA/2J mice, 85% contained small clusters of TUNEL positive cells 
in the retina at 3 days and 1 week post-blast, consistent with our previously published 
findings (Figure 3.1B, D; (Bricker-Anthony et al., 2014a). We have defined these 
clusters as an 85m2 area of retina containing 5 or more TUNEL-positive cells. Clusters 
of TUNEL-positive cells were also present in 3 day post-blast retinas from mice that 
received EPO (Figure 3.1C). Occasional TUNEL-positive cells were detected in the 
EPO-treated 1 week post-blast retinas, but no clusters were found (Figure 3.1E). There 
was no quantitative difference in the number of TUNEL-positive clusters between 
groups at 3 days or 1 week post-blast (Figure 3.1F, G). However, there was an increase 
in the density of TUNEL-positive cells within the clusters in the 3 day post-blast retinas 
from EPO-treated mice, p<0.05 (Figure 3.1H). In contrast, there were no TUNEL-
positive cells detected in the 24h EPO treated, 1 week post-blast retinas as compared 
to an average of 9.8 ± 3.7 dying cells in the other groups, p<0.001 (Figure 3.1I).   
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Figure 3.1. Treatment with EPO beginning at 24h post-blast decreases cell death at 1 week, but 
not 3 days post-blast. Representative fluorescence micrographs of clusters of TUNEL-positive 
cells in sham blast (A), buffer-injected 3-day post-blast (B), EPO-injected 3-day post-blast (C), 
buffer-injected 1 week post-blast (D) and EPO-injected 1 week post-blast (E) DBA/2J retinas. 
Scale bar represents 50m. Bar graphs of clusters of TUNEL-positive cells at 3-days (F) and 1 
week post-blast (G). Bar graphs of the density of TUNEL-positive cells within each cluster at 3 
days (H) and 1 week post-blast (I). ***p<0.001.  
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 Clusters of TUNEL-positive cells were present in retinas from 1-month post-blast 
Balb/c mice treated with rAAV.eGFP (Figure 3.2A) or rAAV.EpoR76E (Figure 3.2B,C) 
regardless of treatment timing. The average number of clusters of TUNEL positive cells 
was similar across groups (Figure 3.2D). However, a subset of retinas from rAAV.eGFP 
treated mice had as many as 25-55 clusters, whereas the rAAV.EpoR76E treated mice 
never had more than 20 clusters of TUNEL-positive cells per retina (Figure 3.2D, red 
Figure 3.2. Treatment with rAAV.EpoR76E after blast decreases the number of TUNEL-positive 
cells at 1 month post-blast in Balb/c mice. Representative fluorescence micrographs of clusters 
of TUNEL-positive cells in retinas from mice injected with rAAV.eGFP (A), rAAV.EpoR76E 1-
month prior to blast (B, pre-blast), or rAAV.EpoR76E 1-day after blast (C, post-blast). TUNEL 
(red), DAPI (blue). Scale bar represents 50m. Scatter plots of the number of clusters of TUNEL-
positive cells (D) and the density of TUNEL-positive cells within each cluster (E). **p<0.01. Red 
boxes indicate statistically significant difference in variance between rAAV.eGFP and both 
rAAV.EpoR76E treatment groups. 
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box; Bartlett’s test of variance, p<0.0001). The density of TUNEL-positive cells within 
each cluster was comparable between the rAAV.eGFP and pre-blast rAAV.EpoR76E 
mice (Figure 3.2E). In contrast, there were fewer TUNEL-positive cells per cluster in the 
retinas of Balb/c mice treated with rAAV.EpoR76E post-blast, p<0.01 (Figure 3.2E). In 
addition, there was a statistically significant difference in density variance between 
these groups, p<0.0001 (Figure 3.2E, red box). With the exception of one cluster in the 
post-blast treatment group, the TUNEL-positive cell densities within the clusters were 
less than 300 cells in the rAAV.EpoR76E groups (Figure 3.2E) while the rAAV.eGFP 
group had several clusters with densities between 400-600 cells.  
 
Timing of EPO therapy affects optic nerve axons after blast 
 A small number of degenerated axons were present at 1 month post-blast in the 
Balb/c mouse injected with rAAV.eGFP as determined by dark profiles from collapsed 
myelin, or loose myelin (Figure 3.3A, C). Rare degenerating axons were also detected 
in the optic nerves of mice treated with rAAV.EpoR76E (Figure 3.3B,D). Upon 
quantification, a decrease in degenerating axons was detected in the mice injected with 
rAAV.EpoR76E after, but not in those injected prior, to blast (Figure 3.3E). The total 
number of axons was similar in all groups, likely due to the small number of 
degenerating axons (Figure 3.3F). 
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Figure 3.3. Treatment with rAAV.EpoR76E decreases axon degeneration in the Balb/c 
optic nerve at 1 month post-blast. Representative brightfield micrographs of optic nerve 
cross-sections from mice given: rAAV.eGFP pre-blast (A), rAAV.EpoR76E pre-blast (B), 
rAAV.eGFP post-blast (C), or rAAV.EpoR76E post-blast (D). Scale bar represents 10m 
and applies to all images. Bar graphs of the percent degenerating axons (E) and the total 
number of axons (F). *p<0.05. 
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Timing of EPO therapy affects glial reactivity after blast 
 
Figure 3.4. Treatment with EPO beginning at 24h post-blast decreases glial reactivity at 1 
week, but not 3 days post-blast. Representative fluorescence micrographs of GFAP 
immunolabeling in retinas from sham blast mice (A), or 3 day post-blast mice injected with 
buffer (B) or EPO (C). GFAP (red), DAPI (blue). Representative fluorescence micrographs of 
GFAP immunolabeling in retinas from sham blast mice (D), or 1 week post-blast mice injected 
with: buffer (E) or EPO beginning at 0hr (F), 6h (G), or 24h (H) after blast. GFAP (green), DAPI 
(blue). Scale bar in D represents 50m and applies to all images. I) Bar graph of the percent of 
retina containing GFAP-positive Müller cell processes. *p<0.05. 
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  In retinas from sham blast mice, GFAP immunolabeling was restricted to 
astrocytes and Müller cell endfeet (Figure 3.4A, D). Focal increases in GFAP 
immunolabeling occurred in the Müller cells of DBA/2J mice at both 3 and 7-days post-
blast (Figure 3.4B, E). GFAP-positive Müller cell processes were typically located within 
the mid-peripheral retina. GFAP-positive Müller cell processes were also present in 
EPO-treated post-blast retinas, although to a lesser extent in the 7-day post-blast group 
that received EPO beginning at 24h after blast (Figure 3.4C, F-H). The decrease in 
GFAP labeling in the latter group was statistically significant when compared to the 
buffer treated group, p<0.05 (Figure 3.4I). The extent of GFAP immunolabeling in the 3-
day post-blast mice was not quantified since the labeling appeared equivalent between 
the buffer and EPO-treated mice. 
 In sham blast Balb/c mice, GFAP immunolabeling was also restricted to 
astrocytes and Müller cell endfeet (data not shown). After blast, GFAP immunolabeling 
extends into the Müller cell processes regardless of treatment (data not shown). 
Quantification confirmed no difference in the extent of retina containing GFAP-positive 
Müller cell processes between groups. 
 
Nitrosative stress post-blast is affected by EPO therapy 
 We detected low levels of immunolabeling in sham blast DBA/2J mouse retinas 
(Figure 3.5A) and bright immunolabeling for nitrotyrosine in focal areas of the retina 
primarily localized to the inner retina after blast (Figure 3.5C,E). Immunolabeling was 
also present, primarily within the inner retina, in all EPO-treated retinas regardless of 
blast exposure (Figure 3.5B,D,F-H). In the 3-day post-blast DBA/2J retinas there was a 
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large increase in nitrotyrosine immunofluorescence in retinas from EPO-treated mice as 
compared to buffer-treated mice, p<0.0001 (Figure 3.5I). In the 7-day post-blast cohort 
nitrotyrosine levels were also increased as compared to sham controls, p<0.001 (Figure 
3.5J). This increase was blunted by treatment with EPO, p<0.001.  
 
 
Figure 3.5. Treatment with EPO beginning at 24h post-blast decreases oxidative stress at 1 
week, but not 3 days post-blast in the DBA/2J mouse. Representative fluorescence micrographs 
of nitrotyrosine immunolabeling in retinas from: sham blast mice injected with buffer (A) or EPO 
(B); 3 day post-blast mice treated with buffer (C) or EPO (D); and 1 week post-blast mice treated 
with buffer (E) or EPO beginning at 0h (F), 6h (G), or 24h (H) post-blast. Nitrotyrosine (green), 
DAPI (blue). Scale bar represents 50m and applies to all images. Bar graphs of quantification of 
the mean anti-nitrotyrosine immunofluorescence intensity in the inner retina of 3-day post-blast 
DBA/2J mice (I) and 7 day sham and post-blast DBA/2J mice treated with buffer or EPO at 24, 
48, and 72h after blast (J). ***p<0.001, ****p<0.0001. 
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Figure 3.6. Treatment with rAAV.EpoR76E alters nitrotyrosine 
immunofluorescence in the inner retina of Balb/c mice after blast. 
Representative fluorescence micrographs of nitrotyrosine immunolabeling in 
retinas from mice injected with rAAV.eGFP (A), rAAV.EpoR76E prior to blast 
(B), or  rAAV.EpoR76E after blast (C). Scale bar represents 50m and applies 
to all images. Bar graph of quantification of anti-nitrotyrosine 
immunofluorescence in the inner retina at 1-month post-blast. *p<0.05, 
**p<0.01. 
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Immunolabeling for nitrotyrosine was also evident at 1-month post-blast in the 
Balb/c mice (Figure 3.6A-C). Nitrotyrosine immunofluorescence was increased in the 
pre-blast rAAV.EpoR76E group, p<0.05, and decreased in the post-blast 
rAAV.EpoR76E group, p<0.01, as compared to rAAV.eGFP injected Balb/c mice (Figure 
3.6D). 
 
EPO therapy increases hematocrit and retinal ferritin levels  
 In the 3-day post-blast mice the hematocrit increased from 43 ± 3.1% (avg ± sd) 
in buffer-injected mice to 46 ± 2.2% in EPO-injected mice, p<0.01 (Figure 4.7A). In the 
7-day post-blast mice, the hematocrit was increased from 42 ± 2.1% in the buffer-
injected mice to 50.5 ± 3.4%, 48.5 ± 3.0%, and 47.6 ± 2.1% in the 0h, 6h, and 24h EPO-
treated mice, respectively, p<0.0001 compared to buffer (Figure 3.7B). The hematocrit 
was also statistically significantly higher in the 0h EPO group as compared to the 24h 
EPO group, p<0.05.  
 We then performed anti-ferritin immunolabeling and quantification of 
fluorescence to determine if these slight increases in hematocrit were sufficient to cause 
an increase in retinal iron levels. The anti-ferritin labeled the photoreceptor inner 
segments, inner nuclear layer, and punctate structures in the inner plexiform layer 
(Figure 3.7). Ferritin immunolabeling appeared similar in buffer-treated, sham and blast-
exposed mice (Figure 3.7C, E, G). However, the amount of labeling appeared increased 
in retinas of mice that received EPO (Figure 3.7D, F, H-J) regardless of exposure to 
blast. Quantification confirmed an increase in ferritin levels in the retinas from EPO 
treated 3-day post-blast retinas as compared to buffer-injected mice, p<0.0001 (Figure 
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3.7K). This increase was primarily due to EPO and not blast since a large increase was 
detected in sham blast mice treated with EPO as compared to buffer injected sham 
mice, p<0.0001 (Figure 3.7L). Like the 3-day post-blast result, there was also an 
increase in ferritin immunolabeling in the EPO treated 7-day post-blast retinas as 
compared to buffer-injected 7-day blast mice, p<0.0001 (Figure 3.7L).  
Despite expressing Epo-R76E rather than wild-type EPO, the Balb/c mice 
exhibited a rise in hematocrit similar to what we detected in the short-term EPO protein 
study in the DBA/2J mice. The hematocrit in mice injected with rAAV.eGFP was 45 ± 
4.0%. In contrast mice treated with rAAV.EpoR76E had a hematocrit of 50 ± 5.0% (pre-
blast cohort) and 57 ± 11% (post-blast cohort), p<0.05 as compared to rAAV.eGFP 
mice. The ferritin immunolabeling pattern in Balb/c mouse retinas appeared similar in all 
post-blast groups regardless of treatment (data not shown). Quantification confirmed 
that there was no difference in ferritin levels between the pre-blast rAAV.eGFP and 
rAAV.EpoR76E groups (data not shown). In contrast, despite an elevated hematocrit, 
ferritin immunolabeling levels were lower in the post-blast rAAV.EpoR76E group, 53 ± 
1.8 (mean fluorescence ± SEM), as compared to the post-blast rAAV.eGFP group, 69 ± 
2.1, p<0.0001. 
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Figure 3.7. EPO increases hematopoiesis and retinal ferritin in the DBA/2J mouse. 
Box plots of hematocrit level at 3 days (A) or 1 week post-blast (B) showing an 
increase in all EPO treated mice. ****p<0.0001. *p<0.05, **p<0.01. Representative 
fluorescence micrographs of retinas labeled with anti-H-ferritin from sham blast 
mice injected with buffer (C) or EPO (D); 3 day post-blast mice injected with buffer 
(E), or EPO (F); 7 day post-blast mice injected with buffer (G), or EPO beginning at 
0h (H), 6h (I), or 24h after blast (J). H-ferritin (green), DAPI (blue). Scale bar 
represents 50m and applies to all images. Bar graphs of the mean anti-ferritin 
immunofluorescence intensity in retinas from 3 days post-blast DBA/2J mice (K), 
****p<0.0001, and sham and 7 days post-blast DBA/2J mice (L), *p<0.05, **p<0.01, 
****p<0.0001. 
 122 
EPO and blast exposure alter oxidative stress gene expression in the DBA/2J 
mouse  
 In the 3 day post-blast, buffer-injected retinas there were increases in the mRNA 
levels of several NADPH oxidases (Figure 3.8A). In particular, Nox4 transcript was 
increased. In addition, expression of Nox 1, Noxa1, and Noxo1 were also increased. 
The expression of these proteins returned to sham levels at 1 week post-blast, however, 
mRNA levels of cytochrome b-245 alpha (Cyba), a NOX interacting protein, were 
increased at that time-point. EPO did not appear to alter expression levels of any of 
these proteins with the exception of decreasing Cyba message levels at 1 week post-
blast.  
 The mRNAs were organized into functional groups and plotted to assess trends 
(Figure 3.8B). There was an increase in expression of peroxireductases (Prdx) and 
superoxide dismutases in the 3 day post-blast, buffer-injected retinas, suggestive of an 
endogenous protective mechanism. In contrast, in all groups there was a decrease in 
gene expression in the EPO-treated 3 day post-blast retinas as compared to the buffer 
group.  
At 1 week post-blast gene expression levels of the antioxidant enzymes were 
comparable to or higher than the 3 day post-blast group. At 1 week post-blast, EPO 
again appeared to cause a decrease in expression of most of these enzymes, although 
levels were higher than in the EPO-treated 3 day post-blast group. One notable 
exception was an increase in Prdx in the EPO-treated 1 week post-blast group. In order 
to further investigate this effect, the expression of individual mRNAs with changes from 
sham of greater than 2-fold was graphed (Figure 3.8C). The increase in Prdx overall is 
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due to increases specifically in Prdx2 and Prdx6. This individual analysis also showed 
increases of 2-fold or greater in Gpx4, Gclm, Sod1, and Sod3 in buffer-injected post-
blast mice at 3 days and/or 1 week and not in the EPO-treated 1 week post-blast 
retinas.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Both blast exposure and EPO treatment induce expression 
changes in oxidative stress-related genes. Bar graph of message 
levels of superoxide ion producing enzymes (A). Bar graph of message 
levels of antioxidant enzymes grouped into functional families (B). B= 
buffer, E=EPO. Bar graph of mRNA transcripts at least 2-fold different 
from the sham controls (C). 
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Discussion 
In agreement with TBI studies, we detected less cell death, optic nerve 
degeneration, glial reactivity, and oxidative stress by systemic injection of EPO (Peng et 
al., 2014). Further, as in other models, we also detected efficacy with EPO when 
treatment was delayed until 24h post-injury (Gawad et al., 2009; Xiong et al., 2010). 
However, the effect was timing specific with efficacy only detected when treatment was 
initiated at least 1 day post-injury and assessed at 1 week or 1 month post-injury. When 
treatment was initiated or stopped earlier, no benefit was found. This effect was not 
strain-specific since we also detected protection in the Balb/c mouse when treatment 
was initiated 3 weeks after blast, but not when it was initiated prior to blast.  
 A surprise finding was the lack of protection in 1 week post-blast retinas treated 
with EPO beginning at 0 or 6h post-blast. In these groups the last EPO injection was 
performed at or before 54h post-injury. Erythropoiesis was increased in all EPO-treated 
mice, causing a correlative increase in retina ferritin levels. The increase in iron could 
promote the Fenton reaction, converting hydrogen peroxide to the much more 
damaging hydroxyl radical and causing greater cell death. The peak of cell death after 
an eye-directed blast in the D2 mouse is 3 days post-blast (Bricker-Anthony et al., 
2014a). EPO has a rapid systemic half-life of approximately 2.5h in rodents (Fisher, 
2003; Lee et al., 2006a). Thus, in addition to having elevated tissue iron levels from an 
increased hematocrit, these mice likely did not have sufficient levels of EPO in the retina 
during the peak of cell death to induce expression of antioxidant enzymes and 
counteract the ongoing oxidative stress. EPO can activate Nrf2 within neuronal tissue to 
induce transcription from the antioxidant response element resulting in increased levels 
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of many antioxidant enzymes (Bond and Rex, 2014). In agreement with this analysis, 
the oxidative stress microarray showed low levels of all tested antioxidant enzymes in 
the EPO-treated 3 day post-blast retinas. This lack of increase in antioxidant enzymes 
likely also explains the lack of benefit in the EPO-treated retinas at 3 days post-blast. 
These results suggest that the benefit of EPO treatment at 1 week post-blast was in 
spite of greater damage at 3 days post-blast.  
  Based on these results, greater therapeutic benefit would be expected by 
treatment with EPO if increased erythropoiesis is reduced. This can be achieved either 
through local delivery of EPO (King et al., 2007; Rex et al., 2009; Tsai et al., 2005; 
Weishaupt et al., 2004) or by systemic delivery of forms of EPO that have attenuated 
erythropoietic activity and yet maintain their neuroprotective function (Dumont and 
Bischoff, 2010; Leist et al., 2004; Sullivan et al., 2012, 2010, 2011a). To test this 
hypothesis, we treated mice with rAAV.EpoR76E and we detected less cell death when 
therapy was initiated after injury, but not prior to injury. EPO-R76E does induce a slight 
rise in hematocrit that is comparable, or lower, than what was induced by EPO 
treatment in the DBA/2J mice. Retinal ferritin levels were not increased in the pre-blast 
treatment group, and were surprisingly decreased in the post-blast group. The greater 
benefit in the post-blast group demonstrates that providing therapeutic levels of EPO as 
late as 3 weeks after blast is still effective.  
 In terms of clinical translation, these results suggest that: 1) oxidative stress is an 
important early component of retinal damage after blast trauma, 2) rapid treatment is 
not critical, 3) intraocular treatment with EPO maybe more effective than systemic 
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therapy as it would avoid induction of erythropoiesis and 4) EPO is protective to retinal 
neurons and axons in the optic nerve after ocular blast trauma. 
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CHAPTER 4 
 
GULO-/- MICE ARE SIMILAR TO BL/6 MICE AFTER BLAST EXPOSURE 
 
Introduction 
Oxidative and nitrosative stress play a significant role in the pathogenesis of 
ocular disease and injury (Ethen et al., 2007; Leal et al., 2007; Neufeld et al., 1999; 
Tanito et al., 2005). Elevations in oxidative stress also occur in both human patients 
with traumatic brain injury (Cernak et al., 2000) and animal models of traumatic brain 
injury (Readnower et al., 2010; Tyurin et al., 2000).  The high metabolic activity of the 
outer retina predisposes both photoreceptors and the RPE to damage from these 
stressors (Strauss, 2005). However, the inner retina is not immune to these stressors 
either, as levels of reactive oxygen species (ROS) in glaucomatous eyes can make the 
difference between cell survival and cell death (Tezel, 2006). 
 High levels of ROS can initiate lipid peroxidation within a cell membrane, which 
ripples through the membrane as one lipid radical steals electrons from a neighboring 
lipid, creating another lipid radical and threatening membrane integrity (Halliwell and 
Chirico, 1993). 4-HNE, a product of lipid peroxidation, modifies several proteins in the 
retina and RPE, including α enolase, triosephosphate isomerase and βB2 crystallin 
(Kapphahn et al., 2006). Modification of α enolase and triosephosphate, which are 
involved in glycolysis and gluconeogenesis, respectively, implies that 4-HNE may 
compromise cellular metabolism, while the impact of βB2 crystallin modification is 
currently unclear (Kapphahn et al., 2006). Modification of photoreceptor outer segments 
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with 4-HNE and malondialdehyde resulted in accumulation of shed outer segments 
within lysosomal compartments of the RPE in vitro (Kaemmerer et al., 2007).  
 In a similar manner, elevations in iNOS within the retina can lead to the formation 
of 3-nitrotyrosine residues on adolase A, another enzyme involved in energy 
metabolism (Koeck et al., 2004). Increased iNOS production is also linked to inner 
retinal cell death in ischemic injury and capillary damage in diabetic retinopathy 
(Sennlaub et al., 2002; Zheng et al., 2007). There is evidence of both lipid peroxidation 
(Mohan et al., 2013) and nitrosative stress (Bricker-Anthony et al., 2014b; a, 2016b) in 
the retina after ocular blast trauma. If 4-HNE and iNOS act on similar proteins and 
pathways in ocular blast trauma, then there is a strong possibility that energy 
metabolism will be impaired in both the retina and RPE. Additionally, photoreceptor 
outer segment turnover could also be impaired within the RPE due to 4-HNE adducts. 
Together, iNOS and 4-HNE can potentially exacerbate retinal injury following ocular 
blast trauma and should be considered when designing a therapeutic strategy. 
 To investigate the role of oxidative stress in ocular blast injury, we used 
gulonolactone oxidase knockout mice (Gulo-/-). The Gulo-/- mice lack the enzyme 
necessary for vitamin C synthesis and must receive vitamin C in their diet, like humans 
(Maeda et al., 2000). In the retina, vitamin C directly scavenges reactive oxygen species 
and regenerates vitamin E (Stoyanovsky et al., 1995). Additionally, Gulo-/- mice 
maintained on a low vitamin C diet exhibit increased levels of oxidative stress in 
neuronal tissue (Harrison et al., 2010), making them an ideal model for exploring the 
role of oxidative stress in ocular blast injury. 
 
 129 
Materials and Methods 
Animals 
Gulonolactone (L-) oxidase knockout mice (Gulo-/-, n=8) were generously 
provided by Dr. Fiona Harrison. Gulo-/- mice were maintained on a low vitamin C diet 
comprised of 0.033 g/l ascorbic acid (Sigma Aldrich, St. Louis, MO) mixed into their 
deionized drinking water, along with 20 μl EDTA to stabilize the ascorbic acid in 
solution. All experimental procedures were approved by the Institutional Animal Care 
and Use Committee of Vanderbilt University, according to AALAC guidelines. Age-
matched Bl/6 animals were used throughout the study.  
 
Ocular Blast Injury 
Isofluorane anesthetized mice were secured and padded within a housing 
chamber that was placed within a larger tube, which shielded the body and head of the 
mouse from blast. The left eye of the mouse was positioned against a hole in the tube 
and was aligned with the barrel of the blast device. An overpressure air-wave with a 
peak pressure of 26psi was produced by a modified paintball marker (Empire Paintball, 
Sewell, NJ).  
 
Ascorbic acid quantification 
The Harrison laboratory measured ascorbic acid concentration in the cortex and 
liver of Gulo-/- mice. Tissue samples were weighed and homogenized in a 1.5 ml 
microfuge tube with 25% (w/v) aqueous metaphosphoric acid and 100 mM sodium 
phosphate buffer containing 5 mM EDTA (pH 8.0), mixed together in a ratio of 2:7. A 
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total of 10 µl of buffer solutions was used for each mg of tissue. The samples were then 
centrifuged at 13,600 g for 4 min at 3° C, and aliquots of the clear supernatant were 
taken for assay of ascorbic acid with ion pair HPLC. 
 
Visual acuity  
Photopic spatial frequency thresholds (i.e. visual acuity) were assessed by 
optokinetic nystagmus (OKN) (OptoMotry, Canada) in awake mice at baseline and post-
blast or sham. A step-wise, masked paradigm was used. Mice were acclimated to the 
testing chamber for 5 min prior to the initiation of each test. The speed of sinusoidal 
grating rotation and contrast were maintained at 0.042 c/d and 100%, respectively. 
 
Electroretinogram (ERG)  
Flash ERGs were performed at baseline and 28 days post-blast in mice dark-
adapted overnight, anesthetized with ketamine/xylazine, dilated with 1% tropicamide, 
and placed on a heated mouse platform within the Ganzfeld dome of a Diagnosys LLC 
Espion Electrophysiology system (Lowell, MA). Mice were exposed to flashes of light 
ranging from -2 to 2.88 log cd*s/m2 with a flash frequency of 2000Hz. For flashes below 
-1 log cd*s/m2, the inter sweep delay was 10 sec, for the -1 log cd*s/m2 flash it was 
15sec, and for all remaining flashes, the delay was 20 sec. Oscillatory potentials (OPs) 
were measured at 3 log cd*s/m2 sampled at 2000Hz with an inter sweep delay of 15sec. 
Amplitudes were measured from trough to peak. 
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Tissue collection 
Mice were euthanized by an overdose of avertin delivered via intraperitoneal 
injection and transcardially perfused with 4% paraformaldehyde (PFA, Electron 
Microscopy Sciences, Hatfield, PA) and phosphate buffered saline (PBS). The tissues 
were collected and stored in 4% PFA. All mice were collected at 1 month post-injury to 
coincide with the peak of cell death and oxidative stress in the Bl/6 mouse (Bricker-
Anthony et al., 2014b) 
 
Statistical analysis 
 The mean and standard error of the mean were calculated and presented for 
each data set. We performed a two-way ANOVA with a Bonferroni’s post-hoc test on 
the visual acuity and ERG data using GraphPad Prism software (GraphPad, La Jolla, 
CA).  
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Results 
Low vitamin C gulo-/- mice and bl/6 mice exhibit similar responses to ocular blast 
trauma 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
To make the Gulo-/- mice vulnerable to oxidative stress, we placed them on a low 
vitamin C diet (0.033 g/l in their drinking water) 1 month prior to any baseline 
assessments.  The Harrison laboratory confirmed the low vitamin C levels using HPLC 
on liver homogenates and found that mice on a low vitamin C diet had significantly 
lower levels than those maintained on a high vitamin C diet (1.0 g/l; Figure 4.1). Despite 
their diminished defenses against oxidative stress, the Gulo-/- mice only exhibited 
slightly diminished visual acuity at 1 month post-blast when compared to Bl/6 mice 
(Figure 4.2). 
Figure 4.1. Confirmation of low ascorbic acid levels by HPLC. 
Ascorbic acid levels in the livers of mice on a low ascorbic acid diet 
(0.033 g/l) are significantly lower than those of mice on a high 
ascorbic acid diet (1.0 g/l). Values represent the mean ± SEM. 
****p<0.0001 
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We also measured ERG amplitudes at baseline and 1 month post-blast in the Gulo-/- 
mice. There were no statistically significant differences between blast-exposed Bl/6 
mice and Gulo-/- mice at 1 month post-injury (Figure 4.3). 
 
 
Figure 4.2. Gulo-/- mice exhibit modest deficits in visual acuity at 1 
month post-blast when compared to Bl/6 mice. Values represent the 
mean ± SEM. *p<0.05. 
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Figure 4.3. Gulo-/- ERG amplitudes don’t change after blast exposure. The ERG 
amax (A), bmax (B) and oscillatory potentials (C) in Bl/6 and Gulo-/- mice at baseline 
and 1 month post-blast. Values represent the mean ± SEM. 
 135 
Discussion 
These initial findings in the Gulo-/- mice suggest that vitamin C deficiency is 
insufficient to exacerbate visual dysfunction after ocular blast trauma. However, these 
are preliminary results based on a small number of mice and we still need to perform 
immunolabeling on the retinas to see if vitamin C deficiency results in increased 
nitrosative stress and cell death. Given these results, a review of the role of vitamin C in 
the regulation of retinal oxidative stress is warranted. 
Among the various cells and tissues in the body, vitamin C levels are highest in 
leukocytes, eyes, adrenal glands, pituitary gland and the brain (Office of Dietary 
Supplements - Vitamin C, 2016). In the eye, vitamin C levels are highest in the retina, 
aqueous humor, lens, retinal pigment epithelium and choroid (Woodford et al., 1983). 
Previous studies have demonstrated that vitamin C supplementation protects the retina 
from light-induced damage in animal models (Woodford et al., 1983; Li et al., 1985) and 
potentially lowers the risk of age-related macular degeneration (AMD) in human patients 
(Seddon et al., 1994; Age-Related Eye Disease Study Research Group, 2001). Vitamin 
C in the aqueous humor can also inhibit neutrophil secretion of myeloperoxidase, which 
contributes to and serves as a marker of oxidative stress (Rosenbaum et al., 1985), but 
we did not observe any invading neutrophils in the Bl/6 eye after blast, so this protective 
mechanism is not relevant for the Gulo-/-. 
The pathogenesis of both light-induced retinal damage and AMD are unlike the 
pathogenesis of ocular blast injury. Retinal light damage causes increased oxidative 
stress that can cause cell death in the outer retina, but its pathogenesis is primarily 
mediated by RPE65 recycling of rhodopsin (Wenzel et al., 2001). AMD is also 
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characterized by increased oxidative stress in the outer retina, but one of the strongest 
risk factors for developing the disease is a common polymorphism in the complement 
factor H gene (Klein et al., 2005). Oxidative stress from retinal light damage and AMD 
often causes lipid peroxidation in the photoreceptor outer segments, which can be 
blocked by vitamin C (Woodford et al., 1983; Bendich et al., 1986; Pennesi et al., 2012). 
However, we have performed some preliminary immunolabeling for 4-HNE in blast 
exposed retinas from Bl/6 mice and have not observed positive immunolabeling. Thus, if 
lipid peroxidation does not contribute to the pathogenesis of ocular blast injury, loss of 
vitamin C would not exacerbate the injury.  
Vitamin C also functions as a direct scavenger of superoxide, singlet oxygen and 
hydroxyl radicals (Bendich et al., 1986). We showed that markers of superoxide and 
reactive oxygen species increased in vivo in the Balb/cJ retina after blast (Bricker-
Anthony et al., 2016b). While we have not tested those markers in the Bl/6 or Gulo-/- 
retinas after blast, we do know that peroxynitrite is likely elevated after blast injury in the 
Bl/6 retina (Bricker-Anthony et al., 2014b) because we observed increased 
immunolabeling for 3-nitrotyrosine. 
 Peroxynitrite, produced by the interaction of superoxide anions with nitric oxide, 
causes the formation of 3-nitrotyrosine (Ahsan, 2013). Interestingly, vitamin C is 
inefficient at competing with nitric oxide for superoxide to block peroxynitrite formation at 
physiological levels (1 mmol/L) and is only partially effective at blocking peroxynitrite 
formation well beyond physiological levels (10 mmol/L) in vitro (Jackson et al., 1998). In 
turn, elevated peroxynitrite can deplete both vitamin C and vitamin E through oxidation 
and then uncouple oxidative phosphorylation in the mitochondria (Vatassery et al., 
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2004). These reactions are incredibly damaging for several reasons. First, oxidation of 
vitamin C prevents it from scavenging reactive oxygen species and blocks its ability to 
regenerate vitamin E (Bendich et al., 1986). Second, depletion of vitamin C causes 
depletion of glutathione (Henning et al., 1991), a critical antioxidant for both lens and 
retinal health (Ganea and Harding, 2006). Third, loss of vitamin E increases lipid 
peroxidation in the retina, which causes photoreceptor cell loss and oxidative damage to 
the RPE (Robison et al., 1979). Finally, uncoupling oxidative phosphorylation in the 
mitochondria reduces ATP production (Vatassery et al., 2004).  
If vitamin C is inefficient at blocking the formation of peroxynitrite at normal 
physiological levels, then low levels of vitamin C are unlikely to exacerbate ocular blast 
injury. Thus, to assess the role of oxidative stress in ocular blast injury, we will need to 
examine the effects of losing an antioxidant that efficiently blocks peroxynitrite 
formation. One such candidate is manganese superoxide dismutase (SOD2), which can 
scavenge reactive oxygen species and effectively prevent formation of peroxynitrite in 
the presence of elevated nitric oxide (Jackson et al., 1998). Mice with only one copy of 
the Sod2 gene exhibit increased oxidative stress in the brain (Liang and Patel, 2004), as 
well as cell loss and mitochondrial abnormalities in the retina (Sandbach et al., 2001). 
Using the Sod2+/- mouse moving forward may provide us with a clearer picture of how 
oxidative stress contributes to the pathogenesis of ocular blast injury. 
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CHAPTER 5 
 
DISCUSSION 
 
Mechanisms of vision loss after ocular blast injury 
 Vision loss is a common consequence of ocular blast injuries in both civilians and 
members of the military (Alam et al., 2012; Erdurman et al., 2011; Thach et al., 2008; 
Weichel et al., 2008; Yonekawa et al., 2014; Phillips et al., 2013).  We also 
demonstrated that vision loss occurs in both Bl/6 (Bricker-Anthony et al., 2014b) and D2 
(Bricker-Anthony et al., 2014a) mice after ocular blast trauma. We do not know the 
specific mechanisms underlying vision loss after blast exposure, but there are several 
possibilities. 
 During the first week post-injury, visual acuity deficits occurred in both Bl/6 and 
D2 mice and ERG deficits occurred in the D2 mice. These alterations in visual function 
coincided with multiple pathological changes in the eye, including RPE vacuoles, 
accumulated debris in the RPE, photoreceptor outer segment damage and 
accumulation in the subretinal space, retinal detachments, photoreceptor cell death and 
increased nitrosative stress. The RPE is critical for visual function in the outer retina, 
due to its role in photoreceptor outer segment phagocytosis, transfer of oxygen and 
nutrients from the choriocapillaris to the photoreceptors, retinoid metabolism and 
forming part of the blood-retinal barrier (Schraermeyer and Heimann, 1999). We 
observed RPE vacuoles throughout the eye in all mouse strains studied; these vacuoles 
are indicative of oxidative stress (Fujihara et al., 2008). Oxidative stress in the RPE is 
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associated with cell death (Garg and Chang, 2003), disruption of tight junctions and loss 
of the blood-retinal barrier (Bailey et al., 2004) and mitochondrial DNA damage and 
impaired energy production (Liang and Godley, 2003). Oxidative stress-induced 
damage to the RPE could also potentially impair retinoid metabolism and could explain 
why we observed a transient decrease in visual acuity in both the D2 and Bl/6 mice 
during the first week post-blast and the transient decrease in the ERG a wave amplitude 
in the D2 mice during the first week post-blast, as both mouse strains exhibited 
extensive RPE damage in the first week post-blast that resolved by 1 month post-blast.  
 However, RPE damage does not explain why we observed decreases in the 
ERG b wave and visual acuity in the D2 mice at 1 month post-blast. It is possible that 
visual dysfunction at 1 month post-blast in the D2 mice was driven by inner retinal 
changes, as damage to the inner retina is associated with reductions in the ERG b wave 
(Block and Schwarz, 1998; Li et al., 2002) and oscillatory potential amplitudes 
(Holcombe et al., 2008). We also observed cell death and nitrosative stress in the inner 
retina at 1 month post-blast in the D2 mice that could have negatively impacted the 
ERG b wave, oscillatory potentials and visual acuity. Since we also observed optic 
nerve degeneration after retinal ganglion cell loss in the D2 retina after blast, 
transmission of visual information to the primary visual cortex may also be impaired 
after blast, which could be assessed using visually evoked potentials (Creel, 2012).  
Altogether, these findings suggest that inner retinal damage and dysfunction may drive 
long-term visual deficits after blast, which is supported by findings in Mohan and 
colleagues’ blast model (Mohan et al., 2013) and by deficits in visually evoked potentials 
in patients with traumatic brain injury (Freed and Fishman-Hellerstein, 1997).  
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Translating mechanical insults into pathological changes 
 While we successfully recapitulated features of ocular blast trauma in three 
different inbred strains of mice and determined how EPO influences neuronal survival 
through modulation of oxidative stress after ocular blast injury, we still lack a true 
mechanistic understanding of what happens in the eye during blast exposure. 
Specifically, we do not know how exposure to a blast wave causes elevations in 
oxidative stress and focal cell death in the retina. However, we can place our data in the 
context of known mechanisms in traumatic brain injury and other biomechanical insults 
to piece together an understanding of what occurs when the eye is exposed to blast.  
 In our injury model, the first event is the impact of the overpressure air-wave. 
Finite element modeling, a computational method used to simulate physics problems, 
has been used to model the impact of an overpressure air-wave on the eye (Rossi et 
al., 2012). The finite element model of blast injury to the eye showed that the pressure 
wave initially impacted the cornea and anterior chamber, caused globe deformation, 
traveled through the vitreous and hit the posterior pole of the eye, as well the bony orbit 
surrounding the eye. Interestingly, the blast wave didn’t stop when it hit the posterior 
pole and orbit, but reverberated throughout the globe, causing small sinusoidal waves of 
positive pressure and negative pressure to impact various posterior structures, such as 
the retina, optic nerve head, RPE and choroid. The reverberation of these small waves 
throughout the posterior chamber could potentially explain why we observed focal 
pockets of damage in the mid-peripheral and central retina instead of uniform damage 
at a single point. This pattern of damage was also seen in blunt ocular trauma 
(Giovinazzo, 1986) and ocular blast trauma (Cockerham et al., 2011) in human patients. 
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Demonstrating that these pressure waves occur in the eye in vivo may be technically 
challenging, but is not impossible. Recent advances in fabrication of pressure sensing 
devices led to the creation of implantable devices capable of measuring intraocular 
pressure in both mouse (Ha et al., 2012) and human (Melki et al., 2014) eyes. An 
implantable device could potentially measure oscillations in intraocular pressure 
produced by a blast wave in the living mouse eye. 
 Reverberating pressure waves in the eye likely subject ocular tissues, including 
the retina, vasculature, optic nerve head, RPE and choroid, to significant mechanical 
stress (Rossi et al., 2012). In our injury model, the gross pathological features of 
mechanical damage were manifested by retinal detachments, photoreceptor outer 
segment damage and RPE damage, which are observed in both blunt ocular trauma 
(Johnston, 1991; Sarrazin et al., 2004) and ocular blast trauma (Erdurman et al., 2011; 
Weichel et al., 2008). Physical separation of the photoreceptor outer segments from the 
RPE disrupts the flow of oxygen and nutrients from the RPE to the photoreceptors and 
causes hypoxia and apoptosis of the photoreceptors within 3 days (Cook et al., 1995; 
Mervin et al., 1999). Retinal detachment also places significant stress upon the RPE 
cells (Mervin et al., 1999), which might explain the extensive vacuolization. However, 
the retinal detachments in our injury model were infrequent in all three mouse strains. 
We also did not observe evidence of apoptotic cell death in the retina after blast, even in 
the photoreceptors. Additionally, RPE damage also occurred in the absence of retinal 
detachments, which is suggestive of direct injury from the blast or cytotoxic stress from 
another source. If photoreceptors underwent necrosis directly in response to blast, 
which has been observed in traumatic brain injury (Zhou et al., 2012), the process 
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would generate reactive oxygen species, extracellular ATP and TNF-α and stress the 
neighboring RPE cells (Zhang et al., 2009). However, this explanation is unlikely as we 
mostly saw positive immunolabeling for markers of necrosis in the Bl/6 and D2 after the 
resolution of RPE damage at 1 month. Therefore, blast likely directly damaged the RPE.  
 Direct mechanical stress from the blast could have also induced pathological 
changes in the retinal vasculature. Endothelial cells are capable of transducing 
mechanical stress into biochemical cascades through ion channels, integrins and 
caveolae (Traub and Berk, 1998). In response to mechanical stress and 
ischemia/reperfusion injury, endothelial cells released nitric oxide (Traub and Berk, 
1998; Topper et al., 1996; Goldstein et al., 1996). This provides a potential explanation 
for the increased nitrotyrosine immunolabeling in the inner retina within days of blast 
injury in our model, as nitric oxide contributes to the formation of peroxynitrite (Pacher et 
al., 2007). Possible contributions of the retinal vasculature to the pathogenesis of ocular 
blast injury could be assessed using an endothelial nitric oxide knockout mouse (Le 
Gouill et al., 2007). 
 Mϋller glia (Lindqvist et al., 2010) and microglia (Sappington and Calkins, 2008) 
are also capable of transducing mechanical stress into signaling cascades that could 
contribute to the pathogenesis of ocular blast trauma. Mechanical stress induced 
elevated intracellular calcium and changes in gene expression in Mϋller glia (Lindqvist 
et al., 2010); these changes could lead to Mϋller glia reactivity, disruption of ion and 
neurotransmitter homeostasis and promotion of retinal degeneration after blast 
(Bringmann et al., 2006). Mϋller glial reactivity occurred within days of blast injury in our 
model and could have possibly been initiated by direct mechanical strain from the blast. 
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Previous research also demonstrated that microglial transduce mechanical stimuli 
through the TRPV1 receptor, which caused increased intracellular calcium, changes in 
gene expression and secretion of Il-6 (Sappington and Calkins, 2008). In another study, 
TRPV1 receptor activation caused microglia to secrete reactive oxygen species, 
indicating that TRPV1 activation might promote microglial reactivity (Schilling and Eder, 
2009). We observed some microglia with morphology suggestive of reactivity in 
conjunction with nitrosative stress and cell death after blast injury in our model, but we 
would need to conduct additional studies to confirm their reactive status. Thus, blast 
injury may have also directly induced microglial reactivity in our model and contributed 
to elevated oxidative stress levels. Since transduction of mechanical stress in both 
Mϋller glia and microglia appears to be mediated by calcium influx (Lindqvist et al., 
2010; Sappington and Calkins, 2008), intraocular injection of a calcium chelator after 
blast could be used to test the hypotheses that glial reactivity is directly induced by 
mechanical stress from blast and results in elevated oxidative stress post-blast. 
 Moving forward, more research is needed to provide a comprehensive 
understanding of the pathological mechanisms of blast injury to the eye. Multiple tissues 
in the retina are affected by blast and may drive excess production of oxidative stress 
after injury, which likely caused the cell death, inflammation and vision loss that we 
observed in our model. Hopefully, this research will inform the development of 
therapeutic agents for the treatment of ocular injuries, as over 2 million people 
experience ocular trauma and related vision loss every year (Kuhn et al., 2006). 
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Potential sources of oxidative stress after blast injury 
 Oxidative stress is common after blast-induced traumatic brain injury in both 
animal models (Readnower et al., 2010; Abdul-Muneer et al., 2013) and human patients 
(Cernak et al., 2000). Due to its heavy oxygen consumption, light exposure and 
enrichment in chromophores and polyunsaturated fatty acids (Beatty et al., 2000), the 
retina is naturally prone to oxidative stress. We also demonstrated that oxidative stress 
increased in the retina after blast injury. There are multiple potential sources of 
increased oxidative stress after blast injury to the eye, which I describe below. 
The retina vasculature could contribute to elevated oxidative stress after blast 
injury. As mentioned in the previous section, endothelial cells secrete nitric oxide in 
response to mechanical stress (Traub and Berk, 1998). There are three known isoforms 
of nitric oxide synthase, including endothelial nitric oxide synthase (eNOS), neuronal 
nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS) (Goldstein et 
al., 1996). eNOS and nNOS are produced constitutively and play important roles in 
vasodilation and synaptic transmission, respectively, while iNOS is produced in 
response to inflammatory stimuli such as TNF-α (Goldstein et al., 1996). eNOS and 
nNOS typically produce small amounts of nitric oxide for a few hours, but iNOS 
produces relatively large amounts of nitric oxide for several days (Goldstein et al., 
1996). All three isoforms of nitric oxide synthase can contribute to the formation of 
reactive nitrogen species like peroxynitrite, which causes 3-nitroyrosine formation (Fink 
et al., 1999). Elevated intraocular pressure (Rokicki et al., 2015) or exposure to 
inflammatory cytokines (Chakravarthy et al., 1995) can trigger iNOS expression in 
endothelial cells. Additionally, superoxide is also required for the formation of 
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peroxynitrite (Pacher et al., 2007). One potential source of superoxide after blast injury 
is red blood cells (Elsayed et al., 1997). Blast exposure was previously shown to induce 
lysis of red blood cells, which subsequently released superoxide (Elsayed et al., 1997). 
Reactive microglial cells also secrete superoxide (Schilling and Eder, 2009). Elevated 
superoxide was also present in the retina after blast injury in our model. The 
combination of superoxide released from damaged red blood cells and reactive 
microglial cells with nitric oxide from the endothelial cells could lead to peroxynitrite 
formation in the inner retina. Peroxynitrite is also capable of diffusing through cell 
membranes (Pacher et al., 2007) and could initiate the spread of injury from focal 
pockets of damage in the retina.  
Mitochondria could also contribute to elevated oxidative stress after blast injury. 
Numerous studies have demonstrated that mitochondrial dysfunction contributes to 
neuronal death and oxidative stress in the aftermath of traumatic brain injury (Xiong et 
al., 1997; Lifshitz et al., 2004; Singh et al., 2006). These effects appear to be primarily 
mediated by an influx of calcium into neurons after injury, which depolarizes the 
mitochondrial membrane and uncouples the electron transport chain, resulting in 
increased production of mitochondrial reactive oxygen species (Singh et al., 2006). We 
do not have any data on calcium homeostasis after blast injury to the retina, but it is 
possible that changes in intraocular pressure during blast exposure could activate TRP 
channels and cause an influx of calcium that disrupts the electron transport chain. The 
TRP channels are mechanoreceptors that are expressed throughout the retina (Gilliam 
and Wensel, 2011); in response to mechanical stress, the TRP channels open and 
allow calcium to the enter the cell (Yin and Kuebler, 2010). Interestingly, one of the TRP 
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family members, TRPM1, is necessary for the ON-bipolar cell response that drives the 
ERG b wave (Shen et al., 2009). Changes in TRPM1 activation could contribute to the 
ERG b wave deficits we observed in the D2 mice.  
Another potential source of post-blast oxidative stress is the necroptosis 
pathway. RIP1 and RIP3, markers of necroptosis, were both increased in the retina after 
blast in both Bl/6 and D2 mice. Downstream of TNF-α receptor activation, RIP1 and 
RIP3 form a complex called the necrosome (Li et al., 2012). RIP3 directly interacts with 
several enzymes involved in cellular energy metabolism, specifically glycogen 
phosphorylase L, glutamate ammonia ligase and glutamate dehydrogenase (Zhang et 
al., 2009). Interaction with RIP3 pushes these enzymes into overdrive and causes 
increased production of reactive oxygen species, depletion of ATP and necrosis (Zhang 
et al., 2009; Moriwaki and Chan, 2013). The necroptosis pathway can also increase 
microglial reactivity and further exacerbate oxidative stress (Trichonas et al., 2010).  
Finally, we also identified another set of contributors to post-blast oxidative stress 
in the D2 mice: the NADPH oxidases (Bricker-Anthony et al., 2016a). The NADPH 
oxidase family, which consists of NOX1-5 and DUOX1-2, was first discovered in 
immune cells (Donkó et al., 2005). In neutrophils, NADPH oxidases were shown to 
catalyze the transfer of electrons from NADPH to molecular oxygen, which generated 
superoxide radicals that the neutrophil utilized to attack foreign invaders (Donkó et al., 
2005). Since their initial characterization in peripheral immune cells, the NADPH 
oxidases have also been identified in other cell types throughout the body and the 
retina, including RGCs, Mϋller glia and microglia (Deliyanti and Wilkinson-Berka, 2015). 
In response to increased intraocular pressure or retinal ischemia, RGCs, microglia and 
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Mϋller glia upregulate expression of the NADPH oxidases, resulting in excess 
production of reactive oxygen species and cell death (Deliyanti and Wilkinson-Berka, 
2015; Dvoriantchikova et al., 2012). Interestingly, the NADPH oxidases are activated by 
increased intracellular calcium (Nauseef, 2008), which could be one the first signals that 
initiates neurodegenerative changes after blast.  
 
Summary 
 These studies demonstrate several things. First, ocular blast trauma induces 
both acute and long-term changes in the retina and optic nerve. Our findings indicate 
that cell death, inflammation and oxidative stress are persistent up to 2 months post-
injury and may continue over time without therapeutic intervention. We also 
demonstrated that we can model various degrees of injury using genetically distinct 
mouse strains, with the Bl/6 representing a mild closed-globe injury phenotype, the D2 
representing a severe open-globe like phenotype and the Balb/cJ representing a 
closed-globe phenotype with features of traumatic optic neuropathy.  
 Secondly, we showed that erythropoietin reduces cell death, nitrosative stress 
and optic nerve damage after injury. However, the timing and treatment delivery method 
are critical. Acute systemic treatment with EPO boosts retinal iron levels and further 
increases oxidative stress in the retina through the Fenton reaction. To avoid these 
damaging side effects, less hematopoietic forms of EPO should be delivered 
intraocularly to prevent increased systemic hematopoiesis.  
 Finally, our preliminary results with the Gulo-/- mice suggest that vitamin C 
depletion is not sufficient to exacerbate ocular blast injuries. Oxidative stress is common 
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after blast in all three of our mouse models and appears to contribute to worse 
outcomes with acute EPO treatment. It is possible that the increased oxidative stress in 
the Gulo-/- retina is too mild to exacerbate the injury. However, we need still need to 
quantify oxidative stress in the Gulo-/- after blast.  
 Together, these findings demonstrate that we can effectively model various 
aspects of ocular blast trauma and test potential treatments for injury, which are greatly 
needed. 
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